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Summary 
 
The possibility of heterologous expression in Xenopus laevis oocytes has greatly expanded 
the knowledge of the properties of several cotransporters, membrane proteins that, 
combining features of  pumps and channels, couple the movement of ions and substrates. 
Transport across the membrane guarantees the reuptake of neurotransmitters from the 
synaptic cleft, the absorption of nutrients, the regulation of osmolarity and ionic 
homeostasis. Some of these proteins are involved in neurological diseases and in drug 
abuse. All the Na
+
/Cl
-
-dependent cotransporters share high homology and possess the 
structural topology of the procariotic prototype transporter, LeuT. The present research 
work was focused on the insect neutral amino acid contransporter KAAT1 (K
+
-coupled 
Amino Acid Transporter 1), cloned from the midgut of the larva of Manduca sexta 
(Castagna et al., 1998;Feldman et al., 2000) and homologous with amino acid transporters 
belonging to the solute carrier 6 (SLC6) gene family. 
The functional role of an highly conserved sequence, consisting of three consecutive 
glycines (Gly85-Gly86-Gly87), has been investigated by alanine scanning mutagenesis; 
this sequence is located in the first extracellular loop of the protein, close to Arginine 76, 
the residue that participates to the external gate of the protein. 
The functional characteristics, i.e. transport activity, apparent affinity, interaction with 
different cations, were derived from electrophysiological measurements (TEVC, Two 
Electrode Voltage Clamp), and uptake experiments. Additional informations about the 
correct targeting to the plasma membrane of the glycine mutants have been obtained 
performing optical measurement of the surface expression by the single oocyte 
chemiluminescence (SOC) technique pioneered by Zerangue (Zerangue et al., 1999) and 
used by others (Haerteis et al., 2009;Bossi et al., 2011).  
Changes in the transport mechanisms observed for many of the analyzed mutants, 
indicated a relevant role of the glycine triplet in the transport function, that it was 
confirmed by the alterations of the uncoupled currents and the apparent affinity. 
The second part of my PhD work, covered the analysis of the relationship between 
temperature and substrate affinity in the ion-coupled cotransporter KAAT1 (from a 
poikilotherm invertebrate) in comparison with rGAT1, the GABA neuronal transporter 
originating from a mammalian (homeotherm) animal. Observations based on the rate of 
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transport, and the effects on the presteady-state currents, i.e. the electrical signal arising 
from the initial steps of the transport cycle (Parent et al., 1992;Parent et al., 1992;Mager et 
al., 1998;Bossi et al., 1999a) were studied in order to evaluate the kinetic properties of the 
cotransport system at more physiological temperatures. A strong increase of 
transmembrane currents was measured in both transporters at higher temperature (30°C); 
the increased maximal transport-associated current (Imax) was counterbalanced by a lower 
apparent substrate affinity (K05). The inverse relationship between affinity and current 
supports previous observations in the intestinal tranporter PepT1(Bossi et al., 2012). 
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1.1  Plasma Membrane Transport 
For the life of the cell the provision of energy and nutrients is fundamental; efflux and 
influx of different substances such us amino acids, sugars, nucleotides and inorganic ions 
are necessary to maintain their biological activities. 
The plasma membrane is an essential component of all the cells of the organism; it acts as a 
barrier maintaining the intracellular environment separated from the outside and is 
selectively permeable to ions and organic molecules. The cell membrane consists of a lipid 
bilayer containing many integral proteins bounded by electrostatic interactions. These 
proteins exert the function of transport, enzymatic activity, signal transduction, cell-cell 
recognition, attachment to the extracellular matrix and the cytoskeleton. 
Transport processes are the basis of the cell physiology and fundamental for survival; they 
involve carrier proteins that play an important role in the cell physiology; transport  
proteins are present in virtually every cell and are essential for life of all prokaryotic and 
eukaryotic organisms; they have different functional and structural properties and are 
divided in two groups: the solute carriers (SLC) and the others transport proteins (Fig.1.1). 
SLC transporters include more than 43 gene families coding for passive transporters, 
exchangers and co-transporters, that show a sequence identity at least of 20-25%. 
 
 
 
 
Fig.1.1: (SLC)- and non-SLC-transporters expressed in the 
    plasma membrane or in intracellular compartment membranes. 
(Hediger et al., 2004). 
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1.2  Neurotransmitter Transporters 
 
Communication between neurons is achieved through release of polytopic glycosilated 
proteins, called neurotransmitters, that use ionic electrochemical gradients to drive the 
transport of substrate with hight affinity (in a range from 1 to 10 µM) with a mechanism 
that in most cases is a cotransport.  Based on their molecular structure, on the distribution 
and on the transported ion, they have been classified (Hediger et al., 2004). Vescicular 
transporters move neurotransmitters into synaptic vescicles regulating the concentrations 
of substances within them; they utilize on a proton gradient created by the hydrolysis of 
adenosine triphosphate (ATP) in order to carry out their work: vescicle ATPase hydrolyzes 
ATP, causing protons to be pumped into the synaptic vescicles and creating a proton 
gradient. Then the efflux of protons from the vescicle provides the energy to bring the 
neurotransmitter into the vesicle.  
For the biogenic amines, synaptic transmission is terminated by integral membrane 
proteins, called neurotransmitter transporters, located on the pre-synaptic terminal. They 
are divided in two major families: Na
+
/K
+
 -dependent transporters (SLC1), responsible of 
the uptake of excitatory aminoacids as aspartate and glutamate (Kanai & Hediger, 2004); 
Na
+
/Cl
-
 -dependent transporters (SLC6), as the GABA, serotonin and catecolamine 
transporters (Chen et al., 2004a). These transporters utilize the asymmetric distribution of 
Na
+
 and Cl
-
 across the plasma membrane to catalyze the thermodynamically unfavorable 
movement of neurotransmitter back into the pre-synaptic neuron for replenishment of 
neurotransmitter stores and subsequent neural firing. As the transport of substrate is 
coupled to ion transport (symport), these secondary active transporters are known as 
neurotransmitter sodium symporters (NSS). Dysfunction of NSS leads to a variety of 
disorders such as orthostatic intolerance and depression. Not surprisingly, these proteins 
are the primary pharmacological targets of antidepressants such as fluoxetine (Prozac) 
which is specific for the serotonin transporter. Furthermore, studies have shown that these 
transporters directly interact with drugs of abuse, cocaine and amphetamine.  
 
 
 
 
4 
 
1.2.1   NA+/ CL- dependent neurotransmitter transporter family SLC6 
 
The SLC6 family is among the largest SLC families, containing 20 genes that encode a 
group of highly similar transporter proteins (Table 1). They are secondary active 
transporters performing transport of amino acids and amino acid derivatives into cells, 
using, as mentioned in the previous paragraph, cotransport of extracellular Na
+
 as a driving 
force for substrate translocation against chemical gradients (Chen et al., 2004a) (Broer, 
2006;Hoglund et al., 2005). In addition, the SLC6 transporters are further classified as 
symporters, in that the coupled transport of Na
+
 is performed in the same direction as 
substrate transport, although a few members also exhibit antiport activity by performing 
coupled-transport of K
+
 (Rudnick & Clark, 1993) like for example, a subfamily of SLC6, 
called NATs (Nutrient Amino Acid Transporters),whom details are explained in the next 
paragraphs.  
 
 
5 
 
 
 
Table 1: List of the proteins of the „solut carriers“ SLC family reporterd by “Human 
Genome Organisation” – http://www.bioparadigms.org/slc/menu.asp. 
 
 
Members of SLC6 family reside in the plasma membrane of neurons, glia and other cell 
types, such as platelets, must cells and basophils. They have also been found in tissues 
such as kidney, liver, placenta, adrenal medulla and the majority of them has a well defined 
biological function and physiological role, including known endogenous substrates, and is 
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divided into four subclasses on the basis of sequence similarity and substrate specificity 
(Broer, 2006)(Fig.1.2). Because the NSS genes were among the founding gene members of 
the SLC6 gene family, alternate designations for the family are often used, such as the 
“neurotransmitter sodium symporters,” the “sodium-neurotransmitter symporter family,” 
or the “Na+/Cl- -neurotransmitter transporter” family (Nelson, 1998;Beuming et al., 2006). 
The first cloned molecule in this family was the neuronal γ-aminobutyric acid (GABA) 
transporter, GAT1(Guastella et al., 1990) and cloning proceeded rapidly to more than a 
dozen known sequences, some of them named according to their primary endogenous 
transmitter such as transporters for norepinephrine (NET), serotonin (SERT), dopamine 
(DAT), glycine (GLyT), and taurine (TauT).  In 1992, Handler and coworkers reported the 
isolation of the canine betaine transporter (BGT-1) cDNA, which was obtained by 
expression cloning in oocytes from a size-fractionated cDNA library constructed from 
MDCK cells maintained in hypertonic medium; mRNA from MDCK cells maintained in 
hy-pertonic medium showed increased induction of betaine uptake in oocytes (Matskevitch 
et al., 1999). Different strategies based on homology with these previous and the on-
coming cDNA sequences from different cDNA sources resulted in the cloning of the rest 
of transporters of this superfamily, whom members share the 40-60% amino acid sequence 
homology. Homologous transporters have been identified in insects, worms, and yeast. 
The sequence analysis combined with biochemical approaches suggested a membrane 
topology with 12 putative transmembrane (TM) helices with intracellular N- and C-termini 
and a large glycosylated loop between transmembrane helices III and IV (Fig.1.3) This 
membrane topology has been experimentally verified across the monoamine (Torres et al., 
2003), GABA (Kanner, 2006) and glycine transporter subfamilies by a large number of 
studies, mainly using specific antibodies (Chen et al., 1997;Navedo et al., 2008) or site-
selective biochemical labeling of Lys and/or Cys residues.  
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Fig.1.2: Phylogenetic tree of the SLC6 transporter family. NSS 
             are found in fours subfamilies and are highlighted in bold 
          (Kristensen et al., 2011). 
 
 
Another structural feature of this transporters family is a pair of Cys residues in 
extracellular loop 2 that form an intraloop disulfide bridge. The loop also contains sites for 
N-linked glycosylation (Olivares et al., 1997). In the decade after the cloning of the NSS, 
substantial efforts were made to identify and characterize the regions and specific residues 
that contribute to core transporter functions such as substrate binding and translocation. 
SCAM (substituted cysteine accessibility) analysis of the GABA and glycine transporters 
has been carried out to a lesser extent, although several key residues for transporter 
function of GAT1 have been identified by mutagenesis studies (Bismuth et al., 
1997;Kanner et al., 1994;Keshet et al., 1995;Mager et al., 1996;Zomot & Kanner, 2003). 
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                                Fig.1.3: Membrane topology of SLC6 NTTs        
                         (Kristensen et al., 2011).  
 
 
This initial topology derived from bioinformatic approach has been confirmed through the 
first crystal structure, obtained by (Yamashita et al., 2005) whose details are described in 
the next paragraph.  LeuT structures have been established as valid templates for molecular 
modeling of the mammalian NSS, and LeuT is emerging as an important model protein for 
biophysical and computational studies addressing the molecular dynamics underlying NSS 
function and pharmacology (Caplan et al., 2008;Celik et al., 2008).  
 
 
1.2.2 Functional and pathological role 
 
 As all the SLC6 transporters are expressed in the central nervous system (CNS), their 
primary physiological role is the regulation of neurotransmitter homeostasis. However, 
some of them are also found in other tissues (see paragr. 1.3), where they serve important 
physiological functions. Their central role is to mediate the rapid uptake from the 
extracellular space of synaptically released neurotransmitter within and around synapses. 
The uptake can be maintained against very large concentration gradients and the kinetics of 
NSS-mediated transport follows the Michaelis- Menten model with substrate KM values in 
the lower micromolar range and maximal turnover rates ranging from 1 to 20 substrate 
molecules per second. The relationship between extracellular concentrations of Na
+
 and Cl
-
 
and transport activity also follows Michaelis-Menten kinetics with KM values in 5 to 50 
mM range (Kristensen et al., 2011). 
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Fours of nine SLC6 transporters represent important drug targets for treatment of a broad 
array of brain diseases in clinical use. For example, GABA transporters are involved in 
seizures and are target of anticonvulsants; serotonin (SERT), dopamine (DAT) and 
noreprinefine (NET) transporters are targets of antidepressants and psychoactive 
substances of abuse such as amphetamine, 3,4-metilen-diossi-metamfetamine (MDMA or 
ectasy) and cocaine. Dysfunctions that involve neurotransporters include Parkinson 
disease, epilepsy, autism, startle disease atc (Table 2). 
 
 
 
Table 2: List of SLC6 transporters: Link to Disease.  
 
 
1.3 …..a structural template for understanding fundamental aspects of SLC6 
NSS function…. 
 
It is important to remind that before the determination of the first high-resolution X-ray crystal 
structure of a bacterial homolog to the mammalian SLC6 transporters, the structural understanding of 
SLC6- NSS was based on indirect observations derived from extensive biochemical and mutagenesis 
studies that provided indispensable insight into transporter topology and secondary structure but 
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limited information on the tertiary structure. This was revised in 2005, when Yamashita et 
collaborators reported an high-resolution X-ray crystallographic structure of a prokaryotic homolog 
to the SLC6 transporters, the leucine transporter (LeuT) from the thermophile bacterium Aquifex 
aeolicus (Deckert, et al. 1998). 
 Although LeuT is evolutionary distant from the SLC6 NSS (20–25% overall sequence identity), 
the protein has proved to be a suitable and highly useful structural and functional template for the 
SLC6 NSS (Singh et al., 2007).  
 
 
1.3.1   Structure of LeuT, a bacterial Na+ /Cl- dependent  transporters 
homologue 
 
The structure of LeuT confirmed many predictions made for SLC6 transporter architecture 
by revealing 12 transmembrane (TM) regions connected by short intra- and extracellular 
loops with intracellular N and C termini (Fig.1.4); all the TMs are almost exclusively α-
helical, except short unwound segments in TM1 and TM6. Several α-helical elements are 
also present in the intra- and extracellular loops. The TMs pack as an intertwined helical 
bundle into a cylindrical shape that can be divided into an interior and outer part; the 
substrate binding site is located at the core of the transporter. The inner ring is formed 
almost exclusively by TM1, TM3, TM6, and TM8 and holds a central substrate binding site 
in which the substrate (Leu) and two Na
+
 ions are accommodated. In all substrate-bound 
LeuT structures, this central substrate binding pocket is occluded from both the external and 
internal medium (Singh et al., 2007;Singh, 2008;Yamashita et al., 2005;Zhou et al., 2007). 
 
Fig.1.4: Topology of LeuT, a bacterial homolog of SLC6 NTTs ( Kristensen et al, 2011). 
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Near this unwound region excepted from TM1 and TM6, that takes part in the substrate 
and ions binding, the segments 3 and 8 are rich in conserved amino acids compared to the 
other members of SLC6 family. These residues have a relevant role in the interaction with 
the substrate and ions. In the Figure 1.5 the parts of the protein in the unwound region are 
visible. In particular, the binding pocket is mostly formed by main-chain atoms of these 
regions interacting with the α-amino and α-carboxy groups of  leucine. 
 
A  B 
       
Fig 1.5: Leucine binding site: A: The insert shows the electron density of the substrate 
leucine and of the two sodium ions (Na1, Na2) between the unwound TM1b (in red) and 
TM6a (in green). B: In a larger view the interaction between the hydrogens bond (dashed 
lines) and ionic interaction are highlighted. 
 
 
In the crystal structure, the L-leucine substrate appears to be found as a zwitterions, the 
binding site is completely dehydrated and specifically, the negatively charged carboxy 
group of the leucine is near the positively charged end of the TM1b helix dipole, while the 
positively charged amino group of  leucine is very close to the negatively charged residues 
on TM1a and on the TM6a helix dipole. In the Fig.1.5B, the exact hydrogen bond are 
shown: the carboxy group interacts with a sodium ion, amide nitrogens from Leu 25 and 
Gly 26 in TM1, and a hydroxyl from Tyr 108 in TM3. Subsequent work showed TM1 and 
TM3 are involved in the traslocation pathway (Kanner, 2003;Melamed & Kanner, 
2004;Zhou et al., 2004;Zhou & Kanner, 2005). Particularly interesting is Tyrosine 108 in 
TM3, because it makes contact with the substrate and also forms an hydrogen bond with 
Leu25, stabilizing in this way the irregular structure near the unwounded region of TM1; 
12 
 
other important residues are Glu 62 which stabilizes the unwound region of TM6, and 
Ser256 which is responsible for stabilizing the amino group of the leucine, and which is 
also conserved in the eukaryotic homologue (the amino acid transporter KAAT1 from 
Manduca sexta) that can transport the same substrate and the details will be better 
discussed in the next paragraphs. The described binding sites, when compared to sequence 
information of mammalian transporters, allow to infer some conclusions about the 
selectivity shown by the euckariotic homologues. In fact, biogenic amine transporters 
NET, DAT and SERT, in the corresponding position of  Gly 24, have an aspartate, which 
substitutes the carboxy group of the substrate (leucine for LeuTAa , GABA for GATs and 
Glycine for GlyTs) and coordinates with sodium.  
The exceptionally high resolution of the present structure indicates with very high 
probability the localization of the two sodium ions (named N1 and N2), binding pocket 
(Fig.1.6). 
 
 
 
Fig. 1.6:  Sodium ion binding sites (Yamashita et al., 2005). 
 
 
They are located halfway across the membrane bilayer within 6 A° of the α- carbon of the 
bound substrate molecule. The Na1 pocket is determinate from the following residues: 
Ala22 and Asn27 from the TM1, Thr254 from TM6 and Asn286 from the TM7. The Na2 
binding site is positioned between TMs 1 and  8 and makes direct contact with Gly 20 and 
Val 23 (TM1) and Ala351, Thr 354 and Ser355 in the TM8 (as shown in Fig 1.6, panel b) 
  These ions have a key role in stabilizing the binding of the L-leucine substrate and also the      
  core of the protein. Na1, making contact with leucine (as mentioned above) may imply a    
  strict coupling in the transport, indicating that probably the first event in the transport   
  activity is the binding of ions inside the transporter and that substrate binding is possible  
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 only after conformational change. Analyzing the sequences of the mammalian transporters, 
it is evident that Na1 site is conserved while N2 site appears less conserved, supporting the 
difference in the stoichiometry of the different transporters. 
As the nomenclature describes, the function of these transporters that belong to the SLC6 
family is dependent on Na
+ 
and in many instances  also on Cl
- 
as cotransported ion, that may 
have the role of stabilizing the identified external gate, supporting some considerations made 
on chloride and its role in the functioning of the mammalian transporters. In two papers 
(Singh et al., 2007;Zhou et al., 2007), it has been shown the crystal structure of LeuT with 
one molecule of a tricyclic antidepressant (TCA) bound. In many respect, the structure 
agrees with and extends the biochemical data on transporters of the NSS family, even if 
some differences exist in the structure and function of the two transporters. For example, the 
neurotransporters require chloride for transport, while prokaryotic transporters do not. The 
majority of mammalian SLC6 transporters, including all nine members of the NSS 
subfamily are functionally dependent on extracellular Cl
-
. In contrast, the function of 
prokaryotic SLC6 homologs, including LeuT, is Cl
-
-independent (Kanner & Zomot, 
2008;Zhao et al., 2010;Zomot et al., 2007). It is remarkable that the negatively charged 
residue is conserved in the prokaryotic transporters but not in the mammalian transporters 
(Zomot et al., 2007;Forrest et al., 2007); structural analysis of LeuT-based homology 
models of GAT1 and SERT with Cl
-
 docked into the equivalent position of Glu290 in LeuT 
showed that this could accommodate Cl
-
 by coordination to the amide group of Gln291 and 
the hydroxyl groups of Ser331, Ser295, and Tyr86 (human GAT1 numbering). 
Accommodated at this site, Cl- is close to Na
+ 
in the Na1 site, thus supporting the idea that 
Cl
-
 is translocated along with Na
+
 and substrate during transport {2041}. Recent studies of 
measurements of currents associated with conformational changes in DAT to study the 
kinetics of the transport mechanism found that increasing intracellular Cl
-
 concentration, 
thus saturating DAT with Cl- during the return step, facilitated transporter turnover, 
suggesting a variable functional role of Cl- among the SCL6 NSS, which highlights the 
presently poorly understood role of Cl
-
 for the transport function (Oliveria et al., 2007). 
The organization in complex quaternary structures has been hypothesized for the NSS 
transporters: LeuTAa  forms a dimer in the crystal (Yamashita et al., 2005). 
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1.4  Electrophysiological properties 
 
In general, neurotransmitter transporters have lower turnover rates when compared to ion 
channels (10
2
- 10
4 
s
-1 
vs. 10
6
-10
7
 s
-1 
): this feature prevents accurate electrophysiological 
investigations in native tissue. Since the cloning of these transporters and their expression 
in heterologous system, macroscopic currents can be measured with electrophysiological 
techniques, for nearly all transporters. The most powerful electrophysiological method is 
the “voltage –clamp” technique because of its several advantages over other techniques 
used in transport studies, as i) the membrane voltage of the cell is under control; ii) the 
temporal resolution is high; iii) the data are immediately available to be analyzed and 
interpreted. More details of the two electrode voltage-clamped (TEVC) technique, that it 
has been used to perform the experiments in this thesis, is given in the Method section. 
The transporters of the SLC6 family usually display three kinds of voltage dependent 
currents: “transport-associated current”, a coupled-current (Itr) associated to the 
translocation of the substrate;  “presteady-state” current” (Ipre), a transient current; 
uncoupled or “leakage” current. 
The first one, Itr is due to the movement of the ion across the membrane when a specific 
substrate is added to the solution. It depends on membrane potential, concentration of 
substrate and on the presence of the driver ions and it represents a good tool for the 
functional study of a protein. Recordings of these currents were performed in the past in 
our laboratory, in non injected and KAAT1 (insect amino acid transporter) -injetcted 
oocytes, at fixed membrane potential (-80 mV) or using a voltage pulse protocol indicated 
in the Fig.1.7. It was evident to observe a different behavior of the control oocytes respect 
to the injected ones: addition of  the substrate leucine 1mM to the KAAT1-expressing 
oocytes produced an increase on the transport-associated currents.  
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Fig1.7.: Voltage-dependent currents in control and KAAT-1 expressing oocytes. Recordings of membrane 
currents elicited by voltage steps to –160, –120, –40, 0, and +40 mV (from V h =–80 mV) in a control oocyte 
(A) and in a KAAT1-expressing oocyte, before (B) and after the addition (C) of 1mM leucine in the presence 
of Na
+
 ion. 
 
  
Transport-associated current may be used in determining the I/V relationship and the 
apparent affinity of the transporter for the organic substrate varying the concentration of 
the substrate while keeping constant the ionic composition of the solution. In section 
Result, Chapter 3, these properties of KAAT1 cotransporter will be reported, as well as the 
apparent affinity for the Na
+
 driving ion that, it can be determined isolating the transport-
associated current elicited by application of a fixed substrate concentration in the presence 
of different Na
+
 concentrations. 
The Ipre is observed in the absence of organic substrate and is typical of most of the cloned 
SLC transporters (Bossi et al., 1998;Hazama et al., 1997;Lester et al., 1996). It derives 
from the movement of intramembrane charges induced by rapid changes of voltage or 
substrate concentration (Mager et al., 1993) and it may due to the movement of ions inside 
the protein or the movements of intrinsic charges of the transporter itself (Peres et al., 
2004). This transient current appears to be a relevant distinctive feature of the transporter 
proteins and an important clue to understand their function. In the Fig.1.7, the arrows show 
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the transient current elicited by different voltage steps, in KAAT1-expressing oocytes, in 
the presence of Na
+
 ion. 
Finally, the “leakage” current arises from condition in which the transporters can allow the 
occasional translocation of ions even when the substrate is not present (Lester et al., 1996). 
It is elicited by the presence of the substrate and it is believed to be stoichiometrically 
coupled to the movement of substrate, in particular, the charge that shifts across the cell 
membrane through one transport cycle varies from zero (when the net flow of charge is 
zero, for example in the case of SERT) to a maximum of 2 charges (for example the 
isoform GlyT2A of the glycine transporter). 
A peculiar feature of the uncoupled current is its enhancement in lithium and this 
characteristics allow to distinguish transporters from channels, in which Li
+
 cannot 
generally replace Na
+
. An example is shown in the Fig.1.8., reported below. 
 
 
 
Fig.1.8: Representative current traces in response to 200-ms voltage jumps from 
 -160 to 0 m V (Vh= -60 m V) in solutions containing the indicated cation for wt KAAT1. 
 
 
1.5   Transport Mechanism 
 
The electrophysiological properties of transporters together with information derived from 
flux rates measurements and other techniques were used to give hypothetical descriptions 
of the transport mechanism and to propose different kinetic models. Since discovery of 
NSS transporters various theoretical transport mechanisms have been proposed and the 
“alternate access model” is the widely accepted model. The movement across the 
membrane is guaranteed by an extracellular hydrophilic cavity between the compartment 
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and either side of the membrane in which the binding site for the substrate is located. After 
the substrate is bound, the closing of the external gate and the opening of the internal one 
allows the molecule to enter in the cytoplasm (Fig.1.9). The transporter can now go back to 
the initial conformation and interact with a new molecule of substrate. For ion-coupled 
transporters such as the SLC6 NSS, the conformational equilibrium between “inward”- and 
“outward”-facing states is determined by binding of ions and substrate. Although other 
models for this transport have been proposed (DeFelice et al., 2001;Lester et al., 1996), the 
alternating access model form the model for the majority of current efforts directed toward 
establishing the structural mechanisms of transport.  
The increasing number of structures of prokaryotic transporters sharing the LeuT 5+5 
inverted repeat fold is emerging as a very useful platform for elucidating the structural 
basis for NSS transport. Specifically, these structures provide “snapshots of different 
transporter  conformations, captured along what seems to be a transport cycle consistent 
with an alternating access mechanism. 
 
 
 
 
Fig.1.9: Alternating access mechanism and gating regions. A, schematic representation 
of the conformational states the transporters have to shuttle between to move substrate from the 
extracellular space to the cytoplasm. B, cross-sectional illustrations of transporters with a 5+5 internal 
repeat motif crystallized in distinct conformations corresponding to different states in the alternating 
access mechanism (Kristensen et al., 2011). 
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The fact that transporters sharing the 5+5 internal repeated fold also share a general 
transport mechanism allows to use it as template for the development of models of the 
molecular events underlying transport in the SLC6 NTTs (Abramson & Wright, 
2009;Gouaux & MacKinnon, 2005). 
Many other studies have demonstrated that transport- associated conformational changes in 
SLC6 NSS are consistent with predictions from alternating access models; these include 
the use of voltage-clamp fluorometry to show movement of TM1 during transport (Meinild 
et al., 2009) and SCAM analysis to confirm that TM8 lines the intracellular pathway of 
GAT1 (Ben Yona & Kanner, 2009). Furthermore, SCAM analysis of TM5 in SERT shows 
that the intracellular region of this domain becomes exposed to the intracellular side when 
SERT is locked in an inward-facing conformation (Forrest et al., 2008), using SERT as a 
model protein for SCAM experiments to validate the principle motions of the “rocking 
bundle” model. 
 
 
1.6   Nutrient Amino Acid Trasporters (NATs) 
 
As just mentioned above, in addition to neurotransmitter transporters, the NSS family also 
comprises transporters for nutrients, in particular for amino acids, that play fundamental 
roles in several cellular functions including protein synthesis, hormone metabolism, 
catalytic functions, nerve transmission, regulation of cell growth, production of metabolic 
energy, synthesis of purines and pyrimidines, nitrogen metabolism and biosynthesis of 
urea. Molecular mechanisms of accumulation and redistribution of essential amino acids 
are poorly understood in mammals and virtually unknown in other organisms, including 
insects. 
A variety of amino acid transporters with overlapping substrate specificities ensure an 
adequate supply of these important solutes, reviewed in (Palacin et al., 1998) and a 
subgroup of the NSS family comprising nutrient amino acid transporters (NATs) has been 
identified (Boudko et al., 2005). To this new group belongs KAAT1 (K
+
 -coupled Amino 
Acid Transporter), an invertebrate neutral aminoacid transporter cloned from the midgut of 
the larva of the lepidoptera Manduca sexta (Castagna et al., 1998;Feldman et al., 2000). 
The role of insect NATs in the uptake and redistribution of essential amino acids is 
strongly supported by the functional consensus of the five cloned and characterized 
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transporters (Fig.1.10) underlined members of insect NATs, namely A. aegypti aeAAT1, 
M. sexta KAAT1 and CAATCH1, and Anopheles gambiae proteins agNAT8 and agNAT6;  
NATs plasticity and NSS conservation are essential in evolution and imply different 
selection mechanisms (Montell et al., 2002): the second group could be stabilized by 
adaptation to particular substrates (neurotransmitters) and electrochemical homeostasis of 
the neuronal environment. According to (Boudko et al., 2005) the plasticity of NAT 
phenotypes may include tuning of electrochemical properties, substrate affinity, and 
selectivity of NATs in different species. 
 
 
1.6.1  NATs  in the Mammals 
 
The amino acid transporters analyzed by sequence homology fall into the following five 
families: the Na
+
/Cl
-
 -coupled neurotransmitter/amino acid transporter family (SLC6), 
above reported; the EAAT/ASCT transporter family (SLC1); the CAT transporter family 
(SLC7); the 4F2heavy chain/light chain and rBATheavy chain/light chain transporter 
family (SLC3+SLC7); the ATA/SN family of AAAP-related transporters (amino acid and 
auxin permeases, SLC38); the TAT transporter related to the monocarboxylate transporter 
family (MCT, SLC16) (Zhang et al., 2008). Antiport is the prevalent kind of amino acid 
transport in mammalian tissues and this reflects the fact that most tissues or cells have 
excessive amounts of non essential amino acids but may lack essential ones. Almost any  
cell can synthesize alanine, glutamine, glutamate, asparagine and aspartate from metabolic 
intermediates, whereas branched-chain amino acids, aromatic amino acids and most 
cationic amino acids are essential. Antiporters amino acid transporters are very important 
for vectorial transport across epithelia but transport mechanisms are not well conserved 
within families (Palacin et al., 1998). 
For example, it has been shown that neuronal and glial glycine transporters have different 
stoichiometries: the neuronal GlyT2a transported two net charges per glycine, whereas a 
transfer of only one net charge was observed in the glial GlyT1b. Both transporters 
depended on the presence of chloride and a cotransport of 1 mol 36 Cl per mol of substrate 
was demonstrated in both cases (Dodge & Scott, 2000). The Na
+
-cotransport stoichiometry 
is not the only mechanistic parameter that varies in this family. GlyT1b and GlyT2a 
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mediate the cotransport of chloride, whereas an exchange of chloride ions was observed in 
the case of the GABA transporter GAT-1 (Hennigan et al., 1993a). Although transport 
depends on Cl
–
, Cl
– doesn’t contribute to the driving force of the transporter because it is 
exchanged. The 2Na
+
/1GABA cotransport is thus accompanied by the net transfer of two 
charges per cycle rather than one (Loo et al., 2000). 
The family of Na
+
/Cl
-
-dependent amino acid transporters has evolved in a separate way in 
some insect species such as lepidoptera. In contrast to the Na
+
 gradient that prevails in 
mammalian and other eukaryotic tissues, a K
+
 gradient is exploited for intestinal 
reabsorption of amino acids in these insects (Castagna et al., 1998;Miszner et al., 
2007;Caterina et al., 1997). An excellent review by Kilberg’s group (Malandro & Kilberg, 
1996) describes the molecular biology of the amino acid transporters cloned in 1995. The 
molecular identification of amino acid transporters or related proteins leads to ongoing 
studies on the structure-function relationship and the molecular genetics of the pathology 
associated with these transporters.  
Epithelial resorption of amino acids across the apical membrane in the kidney and intestine 
is thought to be carried out by four different transporters (Broer, 2008). Anionic amino 
acids are taken up by a Na
+
-dependent aspartate/glutamate transporter, which has been 
designated system X
-
AG . Molecular cloning has identified this transporter as EAAT3. 
Cationic amino acids are taken up by system B
0,+
 the molecular correlate of this transporter 
being the heteromeric amino acid transporter rBAT/B 
0,+
 AT (Broer, 2009); proline and 
glycine are thought to be transported by the IMINO system (Broer et al., 2004b). 
The primary mediator for absorption of neutral and many essential amino acids across the 
apical membrane of the small intestine and kidney is the Na
+
 -dependent transporter 
B
0
AT1 [broad neutral (0) amino acid transporter 1; SLC6A19 (solute carrier family 6 
member) (Castagna et al., 2009). System B
0
 has been characterized in jejunal brush border 
vesicles,  bovine epithelial cells,  and Caco-2 cells. Many studies suggest this system is a 
Na
+
 -dependent, chloride-independent transporter that accepts a wide variety of neutral 
amino acids. Failures to resorb amino acids in the kidney and intestine underlie a number 
of inherited transporter diseases, with and mutations of system B
0
 thought to cause Hartnup 
disorder, a symptomatically heterogeneous disease, largely limited to the kidneys and the 
small intestine and characterized by high levels of fecal amino acids and renal 
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aminoaciduria. Hartnup disorder has been a model disease because it illustrates the 
principles of amino acid resorption in epithelial cells.  
 
 
1.6.2  NATs in the Insects 
 
A phylogenomic analysis suggests that of 10 SLC families participating in mammalian 
amino acid transport, 9 are present in insect, two of which, SLC6 and SLC7, represent the 
major component of essential amino acid transport (Boudko, 2012). The subfamily, 
comprising NATs exist in Bacteria, Archea, Protozoa, Fungi ad Metozoa; other 
mammalian representatives of these clusters have been recently cloned and characterized 
(Broer et al., 2004b;Broer, 2006;Verrey et al., 2005). B
0
 and IMINO system mentioned 
above include in the same cluster pairs of orthologous transporters found in insect genomes 
and defined as mammalian and insect NATs (Fig.1.10). B0-like functionality was also 
reported earlier in two NATs cloned from Manduca sexta (Ms): KAAT1 (Castagna et al., 
1998) and CAATCH1 (Quick & Stevens, 2001). The caterpillar transporters form an 
insect-specific NAT cluster with 2–9 genes found in genomes of other insect species. 
MsKAAT1 is the first characterized in the midgut of Manduca sexta NAT of the SLC6 
family (Castagna et al., 1998). Several NATs-SLC6 members, as AeAATI in mosquito B
0
-
like NAT and DmNAT1 in D. melanogaster have been characterized to explore 
mechanisms for the essential amino acid absorption in model dipteran insects. The 
identification and functional characterization of new B0 -like and narrow specificity 
transporters of essential amino acids in fruit fly and mosquitoes leads to a fundamentally 
important insight: NATs act as the active core of a transport network that mediates active 
alimentary absorption and systemic distribution of essential amino acids. 
The expression of all analyzed NATs in the posterior and anterior regions of the larval 
alimentary canal correlates with nutrient amino acid absorption (posterior midgut) and 
secretory functions (salivary gland and cardia). From the results of heterologous functional 
characterization, insect NATs represent normally rectifying (unidirectional) mechanisms 
that are predominantly driven by Na
+
 motive force. 
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       Fig.1.10: Phylogenomic tree of selected insect and mammalian SLC6 families (Boudko, 2012). 
 
 
Many insects NATs are also capable of using an inward K
+
 motive force that may exist in 
specific conditions when high extracellular activity of K+ ions and large negative 
transmembrane voltages reverse K
+
 flux.  
NATs, such as in the mammalian B
0
ATs (Broer et al., 2004a) and caterpillar KAAT1 
(Castagna et al., 1998), also reflect adaptations of these organisms to a high (in mammals) 
versus trace (in caterpillars) availability of Na
+
 in the animals’diets. The availability of Na+ 
and K
+
 also varies over the life history of insects. Even high extracellular Cl
- 
concentrations facilitate the functions of some insect NATs. 
The first structure of the first NAT from thermophilic bacterium Aquifex aeolicus, LeuT, 
revealed substrate and ion-binding sites in substrate occlusion and outside in open 
conformations. The canonical structure of SLC6 members, including 12 transmembrane 
domains, is illustated above in the Fig.1.3. 
In summary, functionally explicit NATs and NSS provide a unique model for the study of 
the evolution and structural adaptation of membrane transport proteins. Essential and 
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lineage specific NATs appear to be better suited than the highly conserved NTTs as targets 
for selective and environmentally safe management of disease vector mosquitoes and 
agriculture pest insects (Boudko et al., 2005). 
 
 
1.7   KAAT1 (K+-coupled Amino Acid Transporter1) 
 
1.7.1  Lepidopteran Cotransporter  
 
The amino acid transport in the insects has similarities and also differences with the 
mammalian systems. The principal difference depends  on body fluids composition: in the 
invertebrate, the Na
+ 
concentration is very low and furthermore, in midgut cells the Na
+
/K
+ 
ATPase, which in mammals maintains the sodium and potassium gradients across the 
membrane, is not detectable. 
Despite its broad substrate spectrum, KAAT1 shows a notably different substrate selectivity 
and affinity profile vs. mammalian B0. In fact, it can efficiently use the inward K+ gradient in 
addition to the canonical Na
+
 coupling of the mammalian B
0
 system (Castagna et al., 1998). 
The heterologously expressed KAAT1 mechanism has L-amino acid selectivity with 
approximately even transport capacity for absorption of L-enantiomers of F, L (Km Leu = 
123 lM) M and I (Castagna et al., 1997). The absorptive epithelium of the tobacco 
hornworm  Manduca sexta is mainly formed by two types of cells: columnar and globet cell 
(see in Fig.1.11). 
Goblet cells express a H
+
 -ATPase that generates a proton-motive force in the first place, 
which in turn is converted into a potassium electrochemical gradient by the action of a 
K
+
/2H
+
 antiporter. The potassium is thereby transported from the hemolymph into the 
lumen. The combined action of H
+
-ATPase and K
+
 n/2H +antiporter generates a large 
potassium electrochemical gradient with a transapical voltage  of approximately -240 mV 
and an alkalinization of the intestinal lumen up to a pH value of about 10. This gradient  is 
used to drive the uptake of amino acids by K
+
 -amino acid symporters, which are allocated 
to columnar cells in the midgut. 
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Fig.1.11: K 
+
 -coupled amino acid transporters in brushborder membranes of insect midgut 
columnar cells. The plasma membrane V-ATPase of goblet cells is an electrogenic proton 
pump which energizes electrogenic K 
+
 secretion via K 
+
 /2H 
+
 antiport (Castagna et al., 1997). 
 
 
Northern blot analysis and in situ hybridization probes showed that KAAT1 is specifically 
expressed with CAATCH1(Cation-anion Activated Amino acid Transporter/Channel) in 
the columnar cells (Castagna et al., 1997;Feldman et al., 2000). The K
+ 
-coupled uptake 
constitutes an important alternative to the strict Na
+ 
- dependence of known vertebrate 
transporters. 
Potassium can be replaced also by other cations, such as Na
+
 and Li
+
, thereby 
demonstrating the relationship of KAAT1 to the Na
+
 -dependent transporters of this 
family. In agreement with its similarity to the Na
+
 and Cl
-
-dependent amino acid 
transporters, amino acid uptake via KAAT1 was also found to be chloride dependent. A 
cotransport stoichiometry of 2:1:1 (K
+
 : Cl
–
 : amino acid) was proposed (Broer & Gether, 
2012). 
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1.7.2    KAAT1  
 
KAAT1 (K
+
-coupled Amino Acid Transporter 1) is an invertebrate transporter for neutral 
amino acid cloned from the midgut of the larva of the lepidoptera Manduca sexta 
(Castagna et al., 1998;Feldman et al., 2000). KAAT1 cDNA contains 2882 bp with an 
ORF from nucleotides 103-2004 that encodes a 634-aa residue protein of 70 kDa.  It shares 
the 38% of amino acid sequence with the neurotransmitters transporters, such as γ-
aminobutyric acid (GABA) transporter, rat GAT1, and rat glycine transporter GLYT2 , as 
well the 37% identity to human brain specific L-proline transporter HPROT (Guastella et 
al., 1990) (Fig.1.12). 
 
 
 
 
 
Fig.1.12:  KAAT1 alignment with sequences of members of the Na-Cl -dependent GABA transporter family: 
Putative transmembrane domains are underlined, and residues considered to be critical for function are 
highlighted by vertical arrows. 
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As mentioned in the paragr. 1.3.1, this insect transporters belonging to NSS as KAAT1 
show high sequence identity with the structural prototype of the family (LeuT). It is 
characterized by 12 TMs connected by short intra- and extracellular loops with 
intracellular N and C termini and it cointains  two inverted repeats, with a central core that 
shows two broken α-helices where the substrate- binding residues are localized (Fig.1.4). 
Furthermore, KAAT1 mediates the electrogenic uptake of neutral amino acids, showing a 
marked stereospecificity toward the L-isomers, except arginine and lysine; leucine, proline, 
threonine and methionine are all transported by KAAT1, as well other neutral aminoacids 
(Soragna et al., 2004). The kinetics properties  are similar to those of neutral amino acid 
transport systems in BBMV from this caterpillar (Caterina et al., 1997). The cation 
dependency, amino acid uptake activity and kinetic properties of KAAT1 have 
subsequently been studied by many workers (Bossi et al., 1999a;Bossi et al., 
2000;Castagna et al., 2002;Liu et al., 2003;Peres & Bossi, 2000;Vincenti et al., 2000). 
Although KAAT1 utilizes K
+
 as driver ion for the transport of amino acid, it can also 
mediate a Na
+
 -coupled amino acid transport (and this ion can activate the amino acid 
transport even at low concentration) and Li
+
 (Bossi et al., 1999b;Castagna et al., 
1997;Hennigan et al., 1993a). Kinetic studies conducted in vitro showed that the Km for 
sodium is five times lower than that for potassium, instead the Na
+
 /vmax  is lower than 
K
+
/vmax ; the high affinity of KAAT1 for Na
+
 possibly allows the midgut cells to uptake 
this ion even from the low concentrations (<5 mM) found in the lumen (200 mM).  
Electrophysilogical data obtained in the past in our laboratory showed that the prestedy-
state current, signalling rearrangements of charges in the membrane electricalfield, 
measured in the presence of K
+ 
98mM is bigger that in a solution cointaining both K
+
 and 
Na
+
(5mM), condition that simulates the physiologicalenviroment. This behavior ensures 
the absorption of Na
+
 which is lacking in the larvae diet. 
As mentioned in the paragr. 1.4, KAAT1, similarly to several other transporters of the 
SLC6 family, displays uncoupled currents which are transmembrane currents observable in 
the absence of organic substrate. These currents show the following selectivity sequence: 
Li
+
 > Na
+
 > K
+
 Rb
+
  Cs
+ 
(Bossi et al., 1999b;Peres & Bossi, 2000). Furthmore, in 
KAAT1 the selectivity order in high Na
+ conditions (98mM) is: Thr ≥ Pro > Met > Leu; in 
high K
+ the order is changed to Leu ≥ Met > Thr.  
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The potency order, in terms of amplitude of transport-assciated currents, depends on the 
driver cation; the substrate selectivity order changes depending on whether K
+
 or Na
+
 is the 
main bathing ion. Figure 1.13 indicates that whereas proline generates the largest currents 
in KAAT1 in the presence of Na
+ 
(panel A), this amino acid is the least effective in the 
presence of K
+
. When the main ion present is K
+
, (panel B) leucine is the amino acid 
producing the largest currents at all potentials. 
The substrate competition experiments  in KAAT1, performed by (Miszner et al., 2007) 
indicate that leucine has a dominant role in the transport current that converges to that 
characteristic of leucine, even when other amino acids capable of larger currents.  KAAT1 
is able to complete the transport cycle in the presence of leucine, though with less 
efficiency if compared to other amino acids. 
 
 
 
Fig.1.13: Transport- associated current (current in presence of substrate – current in absence) in presence 
of different substrates in KAAT1 in presence of Na
+
 (A) or K
+
 (B). All substrates were added at a 
concentration of 500 µM. Data are average currents ± SE from 3 to potassium (Soragna et al., 2004). 
 
 
Although studies addressing the anion dependence of amino acid transport in midgut brush 
border membrane vesicles did not reveal chloride dependence of (Hennigan et al., 1993b), 
however, voltage clamp analysis showed that KAAT1 is Cl
-
 -dependent, because 
replacement of Cl
-
 by gluconate suppressed the amino acid evoked currents. This finding 
suggests a K
+
 to Cl
-
 to amino acid stoichiometry of at least 2:1:1. The Cl- dependence of 
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KAAT1 indicates that there is not only a structural but also a functional similarity between 
KAAT1 and Na+ and Cl- dependent transporters of the GABA family.  
 
In recent years, we have taken advantage of the special features of KAAT1 to investigate 
the structural/functional relationships within the NSS family. Sequence comparisons and 
site-directed mutagenesis studies have allowed us to identify structural determinants of 
transport activity such as residues involved in Na
+
 and K
+
 interaction and in amino acids 
translocation (Castagna et al., 2009;Soragna et al., 2004). 
The research activity performed during my PhD course was mainly focused on the 
investigation of the functional role of an highly conserved sequence, extending from the 
extracellular loop 1 (EL1) to the transmembrane domain 2 (TM2) of KAAT1 in which 
three consecutive glycines (Gly85, Gly86, Gly87) are located. The degree of conservation 
in NSS transporters together with the structural localization suggests that this glycine 
triplet plays a relevant role in transport function; it is located at the extracellular side of 
protein, close one of the residues that participates in the external gate (Arg 30 in LeuT, Arg 
76 in KAAT1, Fig.1.14A). 
This region, highly conserved in SCL6 transporter family (Fig.1.14B), has already been 
studied individually in both GAT1 and SERT (Mao et al., 2008;Zhou & Kanner, 2005) 
with a similar approach; in the two papers the role assigned to the glycine residues was 
different, suggesting that they might have a transport- specific task in each member of NSS 
family that could be related to the substrate transported. 
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Fig.1.14: Homology modelling of KAAT1 structure based on the three-dimensional 
organization of LeuT. A: It is observable the spatial relationships of the glycine 
repeat with the residues forming part of the putative external gate of the transporter 
(Arg76 and Asp460 of 17 KAAT1). Gly85-87, Arg76 and Asp460 are depicted as ball and 
stick,TM1, TM2 and TM10 as ribbons, the rest of the structure as strands. 
B: Alignment of KAAT1, GAT1, SERT and LeuT sequences extending from Tyr82 to Val90 
(KAAT1numbering) in which it is located the highly conserved glycine triplet. 
 
 
The final part of my work was focused on the analysis of the relationships between 
temperature and substrate affinity. The purpose of this investigation was first of all to 
verify if KAAT1 substrate affinity was affected by temperature, similarly to the rat 
neuronal GABA transporter GAT1 previously investigated, and than to examine the overall 
efficiency of the transport, considering that while GAT1 is from mammalian (homeoterm) 
animals, KAAT1 originates from a poikilotherm inverterbrate (Castagna et al., 2009). 
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2.1  Molecular biology 
 
2.1.1 Vectors for heterologous expression 
 
Artificial plasmids are used for the gene cloning and expression and they represent an 
useful tool used to amplify and transfer foreign DNA inside an organism. Plasmids are 
double-stranded circular DNA that can replicate independently, the engineered plasmids 
for amplification show three common features: 
 A replication origin, recognized by the host cell,  
 A poli-linker or multi cloning site (MCS), composed by specific restriction sites 
grouped together, where it is possible to insert the DNA of interest  
 A selective marker that make cells containing the plasmid able to be distinguished 
from the others. Generally are used genes conferring to the host a particular 
antibiotic resistance  
The vector used to prepare the RNA for heterologous expression in Xenopus laevis oocytes 
needs to be constructed with the insert in specific position of sequences with different 
function. First of all, a promoter for the RNA-polimerase (T3,T7 or SP6); the transcription 
efficiency is also influenced by three more factors: a) the lack of initial codon (ATG), 
between promoter and the gene in order to avoid an early transcription; b) the lack of long 
non codifying DNA to limit the formation of secondary structures that may reduce the 
polymerase functionality; c) two post-transcriptional modifications: adding the cap at 5’ 
and poliadenilation at 3’.  
The Cap is a molecule of 7-metiloguanosine that protects the transcript from degradation 
and promotes the association of ribosomes with the 5’ of mRNA. The poliadenilation 
consists in adding 150-300 adenosine at the 3’. The poly- A is not essential for 
transcription but it protects mRNA form ribonuclease and facilitates the transport of the 
mRNA from the nucleus to the cytoplasm. 
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2.1.2  KAAT1 cDNAs 
KAAT1 was cloned from the midgut of the Manduca sexta larvae and it is 2881 bp long 
with an open reading frame of 1905 bp that coding for 634 amino acids (70 kDa) protein; 
the cDNA was insert between NotI and SalI in pSPORT1 (Fig.2.1), an expression vector 
that presents the β-lactamase gene conferring ampicillin resistance (APr) and the reported 
multi cloning site (MCS). At both ends of the MCS there are promotor sites for T7, T3 and 
M13 RNA polymerases. 
 
 
 
 
Fig.2.1:  pSPORT1 vector 
 
 
Another plasmid vectore used has been the pAMV-PA vector, shown in the Fig. 2.2, that it 
is a modified pBS (S/K
+
) vector containing an alfalfa mosaic virus region directly 
upstream from the coding region of the insert At both ends of the MCS there are two 
promoter sites for either T7 or T3 RNA polymerases. The AMV sequence is used to 
promote the ribosomal attack. After the MCS there is a sequence coding for poly adenosine 
and a restriction site used to allow linearization (NotI) an useful procedure for the in vitro 
transcription of the cRNAs. 
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                                              Fig.2.2: pAMV-PA vector 
 
 
 
2.1.3  Flag-Epitope tagging 
 
To allow optical measurements of the surface expression of the transporter proteins, a Flag 
epitope was inserted in a structural region considered not involved in the transport 
mechanism of KAAT1 cotransporter. In particular, the insertion was made into the second 
extracellular loop (EL2) close to transmembrane domains 3 (TM3) of KAAT1 (Fig.2.3), in 
correspondence of PstI site.  
FLAG-tag is the first example of a fully functional epitope tag to be published in the 
scientific literature (Einhauer & Jungbauer, 2001) and it is a polypeptide protein epitope 
consisting of an eight amino acid peptide (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys). When it 
is inserted in a protein sequence, it can be recognized by a specific antibody, improving the 
identification. 
The oligonucleotides encoding for the FLAG epitope were designed in order to contain the 
following nucleotide basis: i) the triplets encoding for the 8 amino acids of which FLAG is 
constituted (highlighted in the sequence reported below); ii) the basis representing the 
restriction sites for the PstI enzyme (red colour); iii) the nucleotides used to the annealing 
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of the flanking region, remaining in the sequence after enzymating cutting (green colour); 
iiii) two nucleotides to keep the FLAG sequence in frame (pink colour). 
 
 Forward  Primer:  
           5’cta gct gca gat tat aaa gat gat gat gat aaa gct gca gga 3’ 
 Backward primer: 
          3’gat cga cgt cta ata ttt cta cta cta cta ttt cga cgt cct 5’ 
 
After the digestion  with the restrinction enzyme PstI, the construct KAAT-pAMV-PA was 
purified using the Wizard SV Gel and PCR Clean-Up System and incubated with SAP 
(Shrimp Alkaline Phosphatase 1U/µL, PROMEGA) at 37°C for 15 minutes, in order to 
completely dephosphorylate it. 
The oligonucleotides encoding for the FLAG epitope were then ligated into the PstI site 
after annealing, in the KAAT1-pAMV-PA sequence; exactly, 1 µg of both the 
complementary oligonucleotides (forward and  reverse) and sterile water were added to a 
reaction volume to 50 µL. The reaction mix was incubated for 2’ minutes at 95°C  and then 
cooled down to less than 25°C, in an suitable thermocycler. This step was used to optimize 
the next ligation reaction performed by T4-DNA ligase (Promega Italia, Milan, IT). 
To ensure that the FLAG-tagged KAAT1-pAMV-PA construct was correctly inserted into 
the oocyte plasma membrane and it was functional, transport parameters were determinate 
by two electrode voltage clamp technique ( explained in details in the next paragraphs), 
after the appropriate sequencing procedure. 
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Fig.2.3: KAAT1 amino acid region used for the FLAG insertion (see panel in grey colour). 
 
 
2.1.4  Alanine scanning mutagenesis 
 
To test the functional importance of the stretch of glycines (Gly 85- Gly 87), highly 
conserved in the NSS transporter family, alanine scanning mutagenesis approach (Bennett 
et al., 2000;Zhou & Kanner, 2005) was used; the technique was accomplished by the site-
directed mutagenesis, obtained by PCR (Polymerase Chain Reaction) using hight fidelity 
DNA polymerase Pfu (QuikChange® Site-Directed Mutagenesis Kit, Stratagene Inc., 
Milan, Italy). 
The following mutations were made: the individual substitution of each glycine with 
alanine; the conversion of the flanking residues Asn 84 and Ala 88 into glycine; the 
generation of the double mutants N84G/G87A and G85A/A88G, in order to obtain a shift 
of the triplet toward the N or the C terminus of the protein respectively. 
Briefly, 20 ng of the plasmids containing respectively the KAAT1-pAMV-PA-FLAG and 
KAAT1-pSPORT1 cDNAs were amplified with 3 units of Pfu DNA polymerase, in the 
presence of the overlapping primers containing in their sequence the mutated codons: 
G85A: 5’-ct ttc atc gcg tac cag aat gca gga ggt gc-3’ 
G86A: 5’-c atc gcg tac cag aat gga gca ggt gct ttc- 3’ 
G87A: 5’-c cag aat gga gga gCt gct ttc ctg gtg cc- 3’ 
A88G: 5’-cag aat gga gga ggt ggt ttc ctg gtg cc- 3’ 
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G85A/A88G: 5’ -ca gga ggt ggt ttc ctg gtg cct tac atc atc- 3’ 
N84G: 5’-ct ttc atc gcg tac cag ggt gga gga ggt gc- 3’ 
N84G/G87A: 5’-ct ttc atc gcg tac cag ggt gga gga gct gc- 3’ 
PCR amplification was performed with 25 thermal cycles of 95°C for 30 s, 55°C for 1 min, 
and 68°C for 14 min. Then, 10 units of DpnI were added directly to the amplification 
reaction, and the sample was incubated for 1 h at 37 °C to digest the parental, methylated 
DNA. JM109 supercompetent cells were finally transformed with 1 μl of the reaction 
mixture and plated onto LB-ampicillin plates (for details, see below). After plasmid 
purification, plasmid cDNAs were fully verified by sequencing (Eurofin MWG Operon 
Biotech). 
 
 
2.1.5  Plasmid amplification, extraction and purification 
 
The vectors containing KAAT1 wt and mutant cDNAs were introduced into JM109 strain 
of E. Coli by the means of the heat-shock procedure following the instructions of the 
bacteria supplier (Promega). Transformed bacteria were then left to grow for about 1 h in 
SOC medium [tryptone 2% (w/v), yeast extract 0.5% (w/v), NaCl 10 mM, KCl 2.5 mM, 
glucose 20 mM], centrifuged, plated on dishes (Petri) containing selective medium (LB-
Agar added with 50 g/ml ampicillin) and incubated over night at 37°C. The day after, 
colonies were picked up and inoculated in liquid selective medium (LB added with 50 
g/ml ampicillin). Bacteria were left to grow over night at 37°C and then the plasmid DNA 
was extracted using Wizard
®
 Plus SV Miniprep (Promega) following supplier’s 
instruction. The extracted DNA was loaded on a 1% agarose gel in TAE 1X buffer to 
check the quality and to estimate the concentration. 
 
2.1.6 mRNA preparation 
In order to achieve an efficient in vitro transcription, the clone containing the cDNA of 
interest has to be linearized in 3’ direction with respect to the coding region. The cDNA 
encoding for the transporter isoforms of interest was linearized with NotI enzyme. Briefly, 
8-10 g of plasmid DNA were digested, then purified using the Wizard® SV Gel and PCR 
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Clean-Up System (Promega) and eluted in 35 l of nuclease free water. 3 l were loaded 
on a 1% agarose gel in TAE 1X buffer to check the linearization. The remaining DNA was 
used for the in vitro transcription as described previously in detail {Bossi, 2007 7200 /id}. 
Briefly, the linearized DNA was incubated at 37°C for 3h in presence of 200 units of T7 
RNA polymerase, 18 μl of 5X Trascription Buffer, 8 μl of 100 mM DTT, 2.5 μl of RNasin 
30 U/μl, 13 μL NTPs mix (ATP, CTP, UTP 10 mM and GTP 0.5 mM), 6.5 μL of 10 mM 
Cap Analog (Promega), 10 μl RNA polymerase 20 U/μl (final volume 90 μL). After 10, 20, 
and 40 min from the beginning of the incubation, 1 μL of 25 mM GTP was added to the 
reaction. After 1 h from the start of the transcription, a mixture of 4 μl of 5X TB, 1 μl of 
100 mM DTT, 1 μl of RNasin 30 U/μl, 5 μl of NTPs mix, 1 μl of T7 RNA polymerase 20 
U/μl, 1 μl of 25 mM GTP, 4 μl of nuclease-free water was added to each sample. After 
three hours, the reaction was stopped by adding nuclease-free water to a volume of 200 l. 
All enzymes were supplied by Promega Italia, Milan, Italy. 
The transcribed cRNA was extracted with phenol:chloroform:isoamyl alcohol, 25:24:1, pH 
6.6, precipitated with LiCl 8 M and washed with 70% EtOH. The dried cRNA was then 
resuspended in a small volume of nuclease-free water and the concentration estimated 
using a spectrophotometer (1 A260nm unit = 40 μg/ml). 
Transcribed cRNAs had a modifications which mimic in vivo conditions: the process of 5’ 
capping. The so called “Cap Analog” is a modified guanine (m7G(5')ppp(5')G) which, 
although is not necessary for the protein expression, increases the translation efficiency 
and also protects the mRNA from degradation. 
 
2.1.7 Heterologous expression in oocytes 
 
2.1.7.1  Frog maintenance 
Expression systems yield a really high number of copies of the protein that allow precise 
biochemical and electrophysiological measurements. In this work, Xenopus laevis oocytes 
have been used as a very convenient heterologous expression system for the cotransporter 
KAAT1 and the mutants.  
Xenopus laevis is a member of the Pipidae family originally from South Africa and able to 
adapt to the laboratory conditions. Xenopus females are kept in the animal house in dark 
plastic aquaria containing chloride-free water, because chloride causes the inactivation of 
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magainine, an antibiotic that helps the epidermis prevent bacterial infections. The water 
needs to be changed every three days and the animals showing infections must be isolated 
and treated. The water temperature is kept between 18 and 21°C. The salinity must be 
controlled to avoid the loss of salts from epidermis and it is necessary to provide a light-
dark cycle of 12 hours, in order to attenuate the natural annual cycles thus limiting 
variability in oocytes production. 
The frogs nutrition was carried out according to the institutional and national ethical 
guidelines. 
 
2.1.7.2  Oocytes  usefulness, isolation and selection  
 
Xenopus laevis oocytes are a powerful expression system (Fig.2.4) with numerous 
advantages: i) high expression rate of exogenous proteins (even after only 18 hours); ii) an 
efficient biosynthetic apparatus which allows all post-translational modifications necessary 
for the functionality and the correct targeting of the protein; iii) high density of proteins 
produced upon cytoplasmic mRNA injection; iv) dimensions appropriate for easy 
microinjection and voltage clamp; v) easiness to maintain in culture for relatively  long 
periods (up to ten) with no particular sterile conditions; vi) possibility of coexpression of 
different proteins in various combinations by simply co-injecting the respective cRNAs; 
vii) low expression levels of endogenous membrane proteins (the endogenous channels 
have been well characterized, thus it is easy to distinguish them from the injected proteins). 
 
 
                                    
Fig.2.4: Exogenous protein expression in Xenopus laevis oocytes. 
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Xenopus oocytes have also some disadvantages: i) the expression of exogenous protein is 
transient; ii) the ideal temperature for their survival (about 18°C) is usually lower than the 
temperature appropriate for exogenous proteins (37°C for mammalian proteins) and this 
can affect the folding process; iii) although quiescent cells, oocytes possess their own 
genetic ensemble which might interfere with the exogenous proteins. 
Oocytes were prepared as previously described (Bossi et.al., 2007).They were obtained 
from adult female Xenopus laevis, the frogs were anaesthetised in MS222 (tricaine 
methansulfonate) 0.10%(w/v) solution in tap water and portions of the ovary were 
removed through an incision on the abdomen. The oocytes were defolliculated by 
treatment with collagenase (Sigma Type IA), 1 mg/ml in ND96 Ca
+
 free, for at least 45’ at 
18°C . After 24 hours at 18°C in modified Barth’s saline solution (MBS), the healthy 
looking selected oocytes were injected with  50 nl of the transporter cRNA diluted to a 
final concentration of 0.25 µg/µl for a quantity of 12,5 ng per oocyte, using a manual 
microinjection system (Drummond). The oocytes were then incubated at 18°C for 3-4 days 
in MBS before electrophysiological studies; during incubation the solution was changed 
every 24 hours. 
The experiments were carried out according to the institutional and national ethical 
guidelines. 
 
 
2.2 Protein localization 
2.2.1 Single-oocyte chemiluminescence 
 
Surface expression of the tagged transporter isoforms was determined by the single oocyte 
chemiluminescence (SOC) technique (Zerangue et al., 1999;Rauh et al., 2010;McAlear et 
al., 2006), that employs enzyme amplification with a chemiluminescent substrate and 
sensitive linear detection with a luminometer.  A monoclonal primary antibody anti-Flag 
M2 (Sigma F3165,10 µg/ml) and goat anti-mouse IgG secondary antibody labeled with 
HRP Jackson ImmunoResearch Laboratories) were used to detect the plasma membrane 
expression. 
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The oocytes expressing different FLAG-KAAT1 isoforms, as well as non-transfected 
oocytes, were washed twice for 5 min in ice-cold ND96 pH 7.6 and fixed with 4% 
paraformaldehyde in ND96 for 15 min, rinsed 3×5 min with equal volumes of ND96, and 
then incubated for 1 hour in a 1% BSA-ND96 blocking solution (used in subsequent 
antibody incubation steps), 1 h in mouse anti-FLAG M2 1 μg/ml in 1% BSA-ND96, 
washed 6x3min in 1% BSA ND96, incubated for 1 hour in peroxidase-conjugated goat 
anti-mouse IgG 1 μg/ml, IgGHRP (Jackson ImmunoResearch Laboratories), washed 
6x3min in 1% BSA-ND96 and then 6x3min in ND96 alone. For chemiluminescence 
readings, oocytes were transferred into a 96 wells plate (Assay Plate White not treated flat 
bottom-Corning Costar) filled with 50 μl SuperSignal Femto (Pierce). Luminescence was 
quantified with a Tecan Infinity 200 microplate reader. The plates were read not later than 
5 minutes after the transfer of the first oocyte. The data were then acquired at least three 
times in 10 minutes and for each oocyte the mean of three readings was calculated. Results 
were normalized to the mean value of wild-type FLAG-KAAT1 for each batch and are 
given in relative light units (RLU). 
 
 
2.3  Electrophysiology and data analysis  
 
Membrane electrophysiology has several advantages over other techniques used in 
transport studies: i) the membrane voltage of the cell is under control; ii) the temporal 
resolution is high; iii) the results may be obtained immediately, data can be analyzed and 
interpreted in real-time, and consequently the protocols can be changed or adjusted during 
the same experimental session. These benefits may be exploited in the study of 
transporters, thereby adding valuable information and significantly increasing efficiency. 
The activity of electrogenic transporters, that translocate electrical charge, by definition, 
during their working cycle, is strongly influenced by the transmembrane potential. Thus, 
tracer flux experiments suffer from some uncertainty, because the membrane voltage is not 
under control, and not only the value of the electrical gradient is unknown, but it is also 
bound to change as a consequence of the electrogenic activity of the transporter itself. A 
more reliable evaluation of the activity of the transporter is obtained instead when the 
membrane potential is “clamped”.  
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2.3.1 Two-Electrode Voltage-Clamp (TEVC) 
 
Transport currents generated by the activity of KAAT1 wt and mutants were investigated 
by classical two-electrode voltage clamp experiments. 
The “voltage-clamp” technique was introduced by Marmont and Cole (Cole et al., 1941) 
and by Hodgkin, Huxley and Katz (HODGKIN et.al., 1952) to study the ionic currents 
underlying the action potential in nerve axons, and it has been extended to the study of 
transporters soon after the cloning and expression of the first transporters in Xenopus laevis 
oocytes (Hediger et al.,1987;Ikeda et al., 1989;Parent et.al, 1992;Mager et.al, 1993). The 
TEVC technique is based on the use of two microelectrodes, one for recording the 
transmembrane voltage and one for passing current (Fig.2.5). The recorded membrane 
voltage is compared to the desired (command) voltage and a compensating current is 
automatically injected into the cell by the appropriate electronic apparatus. In this 
technique the independent (controlled) variable is the membrane voltage, controlled by the 
experimenter, while the dependent (measured) variable is the membrane current.  
 
 
              
 
 
Fig.2.5: Two electrode voltage clamp. Im is the membrane current, Vi is the 
membrane voltage and Vc is the command voltage. 
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When a current takes place due to the activity of the transport systems located in the 
membrane, a negative feedback in the circuitry injects into the oocyte a current that exactly 
compensates the charge flow trough the cell membrane, in order to maintain 
transmembrane voltage under control. In addition to keeping the membrane potential 
constant, membrane voltage changes of any desired form can be applied to the cell by the 
TEVC technique. In the case of ion-coupled transporters, the transmembrane current is an 
indication of the transport activity, and the possibility of accurately controlling the 
membrane potential is particularly crucial in voltage-dependent processes. 
 
2.3.2 TEVC experimental setup 
 
A schematic view of the TEVC experimental setup used in this work is shown in Fig.2.6. 
 
 
Fig.2.6: Schematic representation of the experimental setup 
 
 
The voltage-clamp amplifier (GeneClamp, Axon Instruments Foster City, CA, USA or 
Oocyte Clamp OC-725B, Warner Instruments, Hamden, CT, USA) was connected to a 
computer through an AD/DA (analog-digital, digital-analog) converter (DIgiData 1200, 
Axon Instr.). This device converts the analog signal from the amplifier to a digital signal 
intelligible for the computer, and vice versa. Usually, signals derived from the amplifier 
were also displayed on an oscilloscope (TDS 420, TekTronix Inc., Beaverton, OR, USA). 
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A dissection microscope (Wild M3B, Leica Microsystems AG, Wetzlar, Germany) was 
used to visualize the oocyte and micromanipulators (MM-33, Märtzhäuser Wetzlar GmbH 
& Co. KG, Wetzlar-Steindorf, Germany) were use to move the electrodes. A perfusion 
system consisting of a set (16) of syringes was used to deliver the various solutions to the 
unique solution inlet of the chamber (a modified version of RC-1Z, Warner Instr.). All the 
syringes were connected to the inlet by the use of two manifolds (MP-8, Warner Instr.) and 
were all positioned at the same height in order to have the same flow rate for each solution. 
The recording chamber has a small volume (about 200 l, 85 ml/mm height) which allows 
a rapid solution exchange (about 8-10 seconds in our system). The solution is aspirated by 
a modified acquarium pump through a suction reservoir connected to the oocyte well.  The 
oocyte was impaled by two intracellular glass microelectrodes filled with KCl 3 M and 
having tip resistances between 0.5 – 4 MΩ. These resistance values were usually obtained 
by gently breaking the tips on the bottom of the chamber. Agar bridges (3% agar in 3 M 
KCl) connected the bath electrodes to the experimental chamber. 
All the equipment needed for the recording (dissection microscope, perfusion system, 
oocyte chamber, micromanipulators and reference electrode) is placed inside a Faraday 
cage, in order to reduce the noise derived from electromagnetic fields, and on an anti 
vibration table. The cage and all the instruments inside of it were grounded. 
 
2.3.3 Protocols and data analysis  
 
In voltage-clamp mode the holding potential (Vh) was generally -60 mV (-80 mV for Na
+
 
dependence experiments). 
The voltage pulse protocol used, consisting in hyperpolarizing and depolarizing jumps, 
consisted of 200 ms pulses to test potentials from -160 to +40 mV in 20 mV increments 
(four pulses were averaged at each potential), or in a staircase protocol consisting of nine 
20 mV steps  to test potentials from -140 to +20 mV. The current signal was filtered at 1 
kHz before sampling at 2 kHz. 
The currents remaining after subtraction of the traces recorded in absence of substrate from 
those in its presence were assumed to represent the transport-associated currents. In order 
to compare data derived from different oocytes (with different expression level) or from 
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oocytes from different batches, transport-associated currents were usually normalized at 
the maximum current value recorded at the more hyperpolarized membrane potential used. 
When the substrate was missing transient currents could be recorded. The isolated traces 
were fitted with single exponentials to obtain the time constant of decline, and integrated to 
calculate the amount of displaced charge, after zeroing any residual steady-state transport 
current. 
The experiments were run under the WinWCP version 4.4.6 software (J. Dempster, 
University of Strathclyde, UK, 2012). Data were analyzed using Clampfit 10 (Molecular 
Devices, LLC, Sunnyvale, CA, USA, 2012) while figures were prepared with Origin 8 
(OriginLab Corp., Northampton, MA, USA, 2008). 
 
2.3.4   Extracellular Solutions  
 
The oocyte culture and washing solutions had the following composition (in mM), ND96: 
NaCl 96, KCl 2,  MgCl2 1, CaCl2 1.8, Hepes 5, pH 7.6; MBS: NaCl 88, KCl 1, NaHCO3 
2.4, Hepes 15, Ca(NO3)2 0.30, CaCl2 0.41, MgSO4 0.82, sodium penicillin 10 µg/ml, 
streptomycin sulphate 10 µg/ml, gentamycin sulphate 100 µg/ml, nystatin 10 U/ml, pH 7.6; 
PBS: NaCl 138, KCl 2.7, Na2HPO4 8.1, KH2PO4 1.9, pH 7.6. The external control solution 
during the electrophysiological recordings) had the following composition (mM): NaCl, 
98; MgCl2, 1; CaCl2, 1.8, Mes 5mM. In the others solutions NaCl was replaced by LiCl, 
KCl or TMACl. The final pH value  (7.6) was adjusted with HCl and NaOH. For the 
sodium dose-response experiment, Na
+
 was substituted by equal amounts of 
tetramethylammonium (TMA); the Na
+
 concentrations used were 0.3, 1, 3, 10, 30, 60 and 
98 mM. Amino acids (leucine, threonine, proline) at the saturating concentrations (3 mM 
for proline and threonine, 1 mM for leucine) were added to the same solutions to induce 
transport-associated currents. In the substrate dose-response experiments, the 
concentrations were  3, 10, 30, 100, 300 and 1000 µM for threonine  and 3, 10, 30, 100, 
300 and 1000 µM for GABA. All the substrate were dissolved in sterile water and then 
added to the appropriate solution. 
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The oocyte was perfused continuously in a rapid solution exchange chamber (Warner 
Instruments model RC-1Z, http://www.warneronline.com/), with a washout time of about 1 
s. 
Experiments were performed at room temperature (20–25 °C) except during the studies on 
the effects of temperature in which a range of temperature (20-30
o
C) was used. In this 
case, cold solutions in the reservoirs were heated to the desired temperature just before 
entering the recording chamber. A TC-344A in-line heater controller (Warner Instr. Corp., 
Hamden, CT, USA) with feedback control of the temperature was used. The actual 
temperature in close proximity of the oocyte was continuously monitored through a second 
thermistor placed in the bath.  
 
 
2.4  Radiolabeled amino acid uptake  
 
Besides the recordings of electric signals generated during functioning, another useful 
approach to derive information about the transport process is certainly the uptake of 
radiolabelled substrates (amino acids). 
All the uptake data presented in this thesis were obtained in collaboration with the group of 
Prof. V.F.Sacchi, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università 
degli Studi di Milano, Milano, Italy). 
Amino acid uptake was evaluated 4 days after injection. Groups of 8-10 oocytes were 
incubated for 60 min in 120 µl of uptake solution 100 mM NaCl, 2 mM KCl, 1 mM CaCl2 
,1 mM MgCl2 , 5 mM Hepes/NaOH, pH 8) with 0.1 mM [
3H]leucine (444 kBq/ml, specific 
activity 3.996 Tbq/mmol) or 0.1 mM [
3
H]proline (592 kBq/ml, specific activity 2.775 
TBq/mmol) (all from PerkinElmer Life Sciences). Alternatively, to evaluate the uptake 
induced in the presence of lithium or potassium ions, NaCl was substituted by 100 mM 
LiCl or 150 mM KCl respectively. All uptake experiments were made at room 
temperature. After incubation oocytes were rinsed with ice cold wash solution (100 Mm 
choline chloride, 2 mM KCl, 1 mM CaCl, 1 mM MgCl2 , 5 mM Hepes/ choline hydroxide, 
pH 8), and dissolved in 250 µl of 10% SDS for liquid scintillation counting. 
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KAAT1 induced uptake was calculated as the difference between the mean uptake 
measured in cRNA- injected oocytes and the mean uptake measured in non-injected 
oocytes. 
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As mentioned in the Introduction section, KAAT1 is the first invertebrate amino acid 
transporter cloned in 1998, that using K
+
, in addition to Na
+ 
as driving ion, transports a 
wide range of neutral amino acids. It is 30% identical to the GABA transporter GAT1 
which is the prototype of the Na
+
/Cl
-
 dependent transporters family to which it clearly 
belongs (Castagna et al., 1998). For this reason, it may represent a very useful study-model 
for the understanding of  structure-function relationships.  
Due to its electrogenic amino acid uptake (Liu et al., 2003) and an amino acid selectivity 
(Feldman et al., 2000;Soragna et al., 2004) activated and influenced by the driving ions, 
one of the best ways to study the functionality appears to be electrophysiology, by the 
TEVC (Two Electrode Voltage Clamp) on Xenopus laevis oocytes injected with cRNA 
coding for the transport protein. This technique, with respect to other measurements, has 
the principal advantage that the currents generated by heterologously expressed transporter 
proteins are measured keeping the electrochemical gradient under control. Moreover, 
different conditions may be tested on the same cell, producing better comparison of effects. 
Thirdly, some of the results may be available immediately allowing more efficient 
planning of the experiments; finally, the analysis of the electrophysiological data makes it 
possible to obtain different parameters related to the transport activity of the protein. For 
example, the apparent affinity for the substrate, its turnover rate, etc. 
Classical studies on whole cells (Christensen, 1990) had shown that the electrical charge of 
an amino acid plays a critical role in its interaction with the transporters; information from 
sequence analysis and site-directed mutagenesis may lead to the identification of specific 
amino acid residues that are important for the transport function of KAAT1 (Sacchi et al., 
2003). 
In this work, the attention was focused on the study of the functional role of a highly 
conserved sequence, extending from the extracellular loop 1 (EL1) to the transmembrane 
domain 2 (TM2) of KAAT1 in which three consecutive glycines (Gly85, Gly86, Gly87) 
were found.  
The aim was to evaluate the idea that one or more of the native glycine residues, highly 
conserved in  the NSS/NAT family, might play a role in conformational transitions during 
the transport. Most of the functional information, i.e transport activity, apparent affinity for  
sodium,  interaction with different cations, were derived from electrophysiological 
measurements and also from uptake experiments  in the absence of control of the 
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membrane voltage. Furthermore, to better understand the structure-function relationships, 
additional details were obtained about the correct targeting to the plasma membrane of the 
glycine mutants, performing optical measurement of the surface expression by the single 
oocyte chemiluminescence (SOC) technique pioneered by Zerangue (Zerangue et al., 
1999) and used by others (Haerteis et al., 2009;Bossi et al., 2011). 
The second part of my PhD work was focused on the analysis of the relationships between 
temperature and substrate affinity in the ion-coupled cotransporter KAAT1 in comparison 
with GAT1, and in particular I have investigated the rate of transport and  the effects on  
the presteady-state currents, i.e. the electrical signal arising from the initial steps of the 
transport cycle (Parent et al., 1992;Mager et al., 1998;Bossi et al., 1999a).  
 
 
3.1 KAAT1: the functional role of the highly conserved 
glycines triplet 
 
Within the NSS family, certain regions of the sequence have particularly high incidence of 
identity at the amino acid level; the strongest regions of identity appear to be in the TM1, 
TM2 and EL1, the region between the two TMs that have been examined in SERT(Mao et 
al., 2008) and in GAT-1(Zhou & Kanner, 2005), in the context of a specific glycine 
mutation. From mutagenesis experiments carried out in the conserved glycine triplet region 
in GAT1 and SERT by Zhou Y. and Kanner in 2005 and Mao Y. and co-workers in 2000, 
respectively, it has been inferred that there is a relevant role of the glycine residues in the 
transport activity. In this context, the peculiarity of KAAT1 to be able to transport a wide 
spectrum of neutral amino acids with a potency order  related to driver cation (Soragna et 
al., 2004;Miszner et al., 2007), makes it appropriate to further investigate the role of this 
highly conserved sequence. Interesting observations arise when the glycine triplet of 
KAAT1 is compared to those of the mammalian members of the Na
+
/Cl
-
 family of 
cotransporters, listed above. 
Glycine can introduce flexibility in the protein structure, and in 2002 Jiang Y. and co-
workers (Jiang et al., 2002)showed a glycine residue may act as a gating-hinge in 
potassium channels; furthermore, other evidences have been presented suggesting that 
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glycine residues engineered into the proton-coupled lactose transporter confer 
conformational flexibility to it (Leyland & Dart, 2004). 
 
 
3.1.1  Cell surface expression of glycine mutants 
 
To test the functional importance of the stretch of glycines (Gly 85- Gly 87) highly 
conserved in the NSS transporter family, the alanine scanning approach has been used to 
get the following mutations: the substitution of each residue with alanine; the conversion 
of the flanking residues Asn 84 and Ala 88 into glycine; the generation of the double 
mutants N84G/G87A and G85A/A88G in order to obtain a shift of the triplet toward the N 
or the C terminus of the protein respectively. 
In order to analyze their surface expression, we have inserted in the sequence of the 
KAAT1 transporter, a FLAG epitope (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys), (see Method 
section, Chapter 2) which did not alter its functionality. For the Flag insertion in the 
sequence of KAAT1, we have considered as the best “candidate” an extracellular region, 
of KAAT1, with the smallest functional role, high hydrophobicity and the least homology 
with the other carriers of the family. 
 
 
Insertion of the FLAG epitope did not alterate KAAT1 transport activity 
 
Starting from an holding potential of -60mV and following the protocol which provided a 
jump of 20 mV every 200 ms, first in the hyperpolarizing direction (until -140 mV) and 
then in the opposite direction, up to 40 mV, the electrophysiological behavior observed in 
FLAG-tagged KAAT1 wild type was almost identical to the not tagged one, both in Na
+
 
and in K
+
, in the presence of the substrates threonine and proline at the saturating 
concentrations (3mM and 1mM, respectively); this demonstrated its correct insertion into 
the membrane (Fig.3.1).  
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Fig. 3.1:  I/V relationships of KAAT1 WT and KAAT FLAG, in presence of Na
+
 (A) and K
+
 (B), 
and with the addition of the indicated substrates to the high concentration solutions. 
 
 
To obtain the transport-associated currents, the traces recorded in the absence of the 
substrate were subtracted from those recorded in the presence of the same. From the I/V 
graphs, it was evident that  there was just an insignificant difference in the behavior of the 
KAAT FLAG with respect to wt. 
In the right panel (Fig.3.1), in Na
+
, it is evident as the currents elicited by leucine appeared 
smaller than those elicited by threonine, especially for hyperpolarizing potential.  
 
Analysis of the Mutants surface expression 
 
After testing the functionality of the KAAT1 FLAG, the quantitative expression of the 
glycine mutants transporters in the oocyte membrane was verified. The mutants generated 
by alanine scanning mutagenesis (see in Chapter 2) were expressed and functionally 
characterized using the X. laevis oocytes; the single-oocyte chemiluminescence (SOC) 
technique (portrayed in Method section) was used to quantify the luminescence signal 
proportional to the expression on the plasma membrane. 
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As shown in Fig. 3.2, the single mutants showed a surface localization comparable to wt 
with the only exception of G85A and G87A that were present at the plasma membrane at a 
50% level. The same level of expression for the double mutant G85A/A88G was observed, 
while N84G/G87A mutant was completely undetectable in the oocyte membrane. The 
chemiluminescence was detected from 20 to 40 oocytes from 5 different batches 
expressing the wt and the indicated mutants of KAAT1-FLAG and secondarily labeled 
with peroxidase-conjugated goat anti-mouse (IgG-HRP) are shown. The data were 
normalized to the mean value of the wild-type FLAG-KAAT1 of each batch. 
 
 
 
Fig.3.2: Membrane expression of KAAT1wt and mutants. 
 
 
3.1.2   Analysis of the Transport activity 
 
Radiolabeled amino acid uptake 
 
Figs 3.3 A and B, show the data obtained from the amino acid uptake evaluated in glycine 
mutants, 4 days after mRNA injection, to compare the ability to transport its substrate to 
that of the wild-type. It can be observed that in the presence of a Na
+ 
gradient, G85A, 
G86A, G87A mutants showed 0.1 mM leucine uptake reduced of the 40-50% compared to 
the wild type; the same percentage of uptake reduction it was showed from the mutants in 
53 
 
0.1 mM proline, with the exception of G87A that induced a comparable uptake, despite the 
50% surface expression reduction (Fig. 3.2). The amino acid uptake reduction of G85A 
mutant was concordant with its reduced surface expression. 
As shown in Fig. 3.4A, in the presence of 3mM proline, N84G mutant showed a residual 
transport activity (30% of wt), whereas that of A88G, G85A/A88G and N84G/G87A 
mutants was less than 10% of wt; the data relative to the last one would be in agreement 
with its almost undetectable expression on the plasma membrane.  
 
 
 
  
Fig.3.3: Amino acid uptake and transport associated currents in oocyte expressing the indicated 
glycine mutants in the presence of a Na
+
 gradient: Bars represent 0.1 mM leucine (A) or 0.1 mM proline (B) 
uptake expressed as percentage of wt and are means ± S.E. of at least 30 oocytes from 3 different batches. C: 
representative oocytes expressing wild type. KAAT1 and each of glycine mutants. tested at the voltage to -60 
mV in TMA solution (light gray lines), then changed in Na solution (black lines). The substrates, threonine 3 
mM (dark gray bars), proline 3 mM (black bars) or leucine 1 mM (light gray bars) were added after 
stabilization of current in sodium. Before applying the second and the third substrates, 
the complete recovery to the starting value of the current in sodium was waited. 
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Fig.3.4: Amino acid uptake and transport associated currents in oocyte expressing the indicated 
glycine mutants in the presence of a Na
+
 gradient: Bars represent 0.1 mM proline (A) uptake expressed 
as percentage of wt and are means ± S.E. of at least 30 oocytes from 3 different batches. B: representative 
oocytes expressing wild type KAAT1 and each of others glycine mutants tested at the voltage to -60 mV 
in Na solution (white lines). The substrate proline 3 mM (black bars) was added after stabilization of current 
in sodium. 
 
 
Transport-associated currents 
 
The transport cycles of many members of secondary-active ions cotransporters are 
electrogenic, whereby net charge transfer accompanies cotransport and the partial reactions 
that constitute the transport cycle show voltage dependent kinetics (Andrini et al., 2008). 
Electrophysiological data illustrated below include different current types that are 
55 
 
measurable when an electrogenic transport protein is analyzed. When the proline was 
transported by the G87A mutant (Fig.3.3 C) an uncoupled current (Peres & Bossi, 2000) 
was measured; it was observable in the presence of both driven and driving substrates and 
it usually manifests itself as a current in excess of that associated with the stoichiometric 
charge translocation (Andrini et al., 2008;Perez-Siles et al., 2011). The cotransporters, in 
general, can show one or both type of uncoupled currents (Perez-Siles et al., 2011) but 
there are also reported a transport associated current and a leak current; the definition of 
which is explained in Chapter 2.  
All the oocytes in the experiments here reported were tested 72h after the cRNA injection 
in the presence of NaCl 98 mM and TMA (tetramethylammonium). Figure 3.3C  shows 
records of membrane currents from representative oocytes expressing KAAT1 wild type 
and each of single glycine mutants, tested under controlled and fixed voltage of -60 mV, 
and exposed to three different substrates (threonine and proline, at the same saturating 
concentration of 3mM, and leucine 1mM). 
As expected, the different amino acids are able to generate transmembrane currents;  it is 
known (Bossi et al., 2000;Bossi et al., 1999b) that the KAAT1 wt’s selectivity order in 
high Na
+ conditions (98mM) is: Thr ≥ Pro > Leu, while in high K+ the order is changed to 
Leu > Thr.  
For all the three mutants, leucine application induced an inward transport current that was 
20-40% of that of the wt protein; the same happened for the G85A and G86A mutants, 
when threonine or proline were perfused, while the application of these last two substrates 
elicited in the G87A mutant an inward current similar to that of wt or larger (mainly in 
presence of proline).  
Fig.3.4 shows records of membrane currents from representative oocytes expressing 
KAAT1 wild type and each of others glycine mutants tested under the same voltage 
conditions mentioned above and exposed to the substrate proline 3 mM, whose application 
induced a small inward transport current, approximately of the 10-20% of that the wt 
protein (not shown) in all the three mutants, with the only exception of the N84G mutant. 
In presence on the substrate here added, it generated an inward current comparable to that 
of wt. 
Figure 3.5 illustrates the results obtained from more detailed investigation of the 
electrophysiological behavior over a larger voltage range. The current-voltage (I/V) 
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relationships show that the transport-associated current induced by leucine was highly 
impaired in all mutants; whereas it can be observed a G87A’s behavior similar to the wt, 
when the substrate was threonine.  Replacing the last with the proline , the current 
generated by the G87A mutant was increased, as it happened at the fixed voltage 
experiments. These data, calculated as the difference of the traces recorded in the absence 
from those in the presence of the substrate indicated below, consolidate the previous ones. 
A correlation with the uptake data shown above (Fig.3.4B) is supported also from the 
result illustrated in the panel left bottom (Fig.3.5), where it is possible to observe that the 
transport current induced by proline was greatly impaired in all mutants, except in the 
N8AG isoform. 
 
 
 
 
 
 
Fig.3.5: I/V relationships from wt and mutated transporters, in presence of Na
+ 
and the 
indicated amino acid. Value are means ± SE from 8 to 10 oocytes in each group. The panel 
on the right bottom illustrate the pulse protocol applied. 
57 
 
3.1.3   Estimation of Na+ apparent affinity 
 
The apparent affinity for Na
+
 of the glycine mutants (G85A, G86A; G87A) has even been 
tested: the transport-associated current elicited by a fixed saturating concentration (3mM) 
of the substrate threonine was measured in presence of different Na
+
 concentrations, from 
0.3 to 98 mM. Only the G87A mutant showed a transport activity when the sodium was 
lower than 1 mM. 
The data of the transport current (Fig.3.6), calculated as the difference from the current in 
the presence and in the absence of amino acid, were normalized to the maximal current in 
98mM  Na
+
, 3mM Thr (Relative inward (-1) current in the graph) and fitted by Logistic 
equation. The values of the sodium concentrations giving rise to half of the maximal 
current are indicated in the table inside the Fig 3.5. The Na
+
 apparent affinity decreased for 
the G85A and G86A mutants (K50 =64±2.2 and 62±2.8 mM respectively), instead for the 
G87A mutant this parameter increased (K50 =9±1.2 mM), if compared to the wild type (K50 
= 34±7 mM). 
 
 
 
Fig 3.6: Apparent affinity for Na
+
in the mutated isoforms: The values of transport 
current are obtained at -80 mV. In the inset, the table reports the fitting values for the 
different mutants. The data were from two batches and from 4 to 12 oocytes for 
each Na
+
concentration. 
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The difference in the apparent affinity for Na+ and the alteration of amino acid uptake and 
of the transport-associated currents observed in KAAT1 mutants, suggested to investigate 
if the modification in the glycine triplet could also alterate the interaction with the other 
KAAT1 driving cations: Li
+ 
and K
+
. 
 
 
3.1.4   Cation interaction 
 
 
Although in the presence of Li
+
, G87A mutant was able to transport leucine inducing an 
uptake comparable to that of  KAAT1 wt (see Fig. 3.7A), the G86A mutant exhibited a 
transport activity reduced to 50% of wt while the G85A mutant was inactive. 
In order to analyze the transport current in lithium, it has been decided to use the proline as 
substrate, considering that the leucine elicits a large leak current in the NSS family 
transporters. In this way it could be showed the transport current as the difference of the 
current  in the presence and in the absence of the substrate. In fact, as reported in (Bossi et 
al., 2000), the addition of leucine to the Li
+
 solution, at negative potential, switches the 
transporter from the leak mode to the transport mode, blocking the large leak current, so 
that after the subtraction the resulting transport current shows an “apparent” outward 
direction. Differently, with the proline, the transport current is larger and the difference 
gives an inward transport current. The I/V relationships (Fig.3.7B) of the transport current 
here reported in the presence of 100 mM LiCl with 3mM proline confirmed the uptake data 
obtained in 0.1mM leucine (Fig. 3.6A): G85A was inactive, G86A was similar to the wild 
type and finally G87A showed a larger current. 
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Fig. 3.7: Amino acid uptake and transport associated currents measured in the presence of a Li+ gradient. 
A) Data are expressed as percentage of wt and are means ± SE of 30 oocytes from 3 different batches. 
Inset:0.1 mM   leucine uptake measured in KAAT1 wt expressing oocytes or in non injected oocytes as a 
control. B) Data were obtained by subtracting the traces recorded in the absence from those recorded in the 
presence of the indicated substrate. Values are means ± SE from 4 to 6 oocytes in each group. 
 
 
Analyzing the interaction between the mutants and K
+
, it was observed that the G87A 
mutant showed a transport activity of 150% compared with wt; the G86A mutant activity 
was reduced to 20% and G85A mutant was inactive (Fig.3.8A). 
Data from electrophysiological analysis showed that in the presence of 150 mM KCl, all 
three mutants exhibit a similar reduced transport current (Fig.3.8B). This apparent 
discrepancy with the uptake data is due to the transport current estimation that is usually 
calculated as the difference of the current in the presence from that in the absence of the 
amino acid. In this case, a larger “leak” or “uncoupled” current compared to wt has been 
observed in the G87A mutant-expressing oocytes  (Fig.3.8). Indeed, in uptake conditions 
without cell potential control, the high concentration of K
+ 
generates a depolarization of 
the membrane voltage until value around 0 mV. It should be noted that under these 
unfavorable conditions the G87A mutant, which has a lower expression level than wt 
(Fig.3.1) still exhibits a larger leucine uptake. 
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Fig.3.8: Amino acid uptake and transport associated currents measured in the presence of high external 
concentration of K
+
.
 
A) Data are expressed as percentage of wt and are means ± SE of 24 oocytes from 3 
different batches. Inset: 0.1 mM leucine uptake measured in KAAT1 wt expressing oocytes or in non-injected 
oocytes as a control in the presence of 150 mM KCl. B) Data were obtained by subtracting the traces 
recorded in the absence from those recorded in the presence of leucine. Values are means ± SE from 4 to 6 
oocytes in each group. 
 
 
3.1.5  Leak currents 
 
The determination of the leak currents in KAAT1 and glycine mutants, obtained as the 
difference between the level in presence of Na
+
, Li
+
, K
+ 
(ion solution I-Iion) and the level in 
TMA
+
 solution (Bossi et al., 1999a;Bossi et al., 1999b) led us to two interesting aspects: 
the leak currents were altered in G85A and G86A mutants, in particular the Li
+
 current was 
close to 0 in the first of them, and reduced in the second. Furthermore, in these two 
mutants the Na
+
 current was lower than in the wt. The G87A had instead the greatest 
uncoupled currents in all the three tested cations (Fig.3.9). 
Non-injected oocytes were tested as controls and, as shown in the figure reported below, 
no uncoupled current could be detected in solutions containing Na
+
 and Li
+
, differently 
from K
+
.
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Fig. 3.9: Leak currents in KAAT1 and glycine mutants. Oocytes expressing KAAT wt (n=12), 
glycine mutants (n=14)and non-injected oocyte (n=7). Data represent means ± SE from batches. 
 
 
 
3.2  Temperature effects on the transport activity of ion-
coupled cotransporters 
 
Studying the effects of the temperature on the kinetics and amplitude of the transport 
characteristics represents an useful means to obtain information on the nature of the 
process, since the temperature coefficient Q10 is related to the complexity of the 
conformational changed involved. It allows to discriminate between the mechanisms 
generated from diffusional processes (Q10 < 1,5) and those involving conformational 
changes (Q10  > 2). 
All ion-coupled cotransporters tested so far to analyse the effects of temperature have 
shown changes in transport activity with Q10 values of about 3 or more (Hazama et al., 
1997;Binda et al., 2002;Hilgemann & Lu, 1999;Bacconi et al., 2007;Bossi et al., 
2012;Broer, 2002). 
On the basis of considerations obtained from a recent work in our laboratory, on a 
mammalian intestinal transporters of oligopeptides PepT1, in which it has been observed 
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that the apparent substrate affinity was significantly affected by temperature, it has been 
decided to think of a kinetic interpretation of the substrate affinity in which a greater 
substrate concentration is required to keep up with the ability of a faster turnover of the 
transporter. 
 
 
3.2.1  Apparent affinity changes induced by temperature in KAAT1 
 
The effects of the temperature on substrate affinity have been studied, first, in the amino 
acid transporter KAAT1 then, in rat neuronal GABA transporter GAT1, originating 
respectively from two different species, from a poikilotherm inverterbrate the first one,  
from mammalian animal (homeotherm) the second one. 
For KAAT1 experiments, a staircase voltage protocol was used to minimize temperature 
fluctuations during the recording (Bossi et al., 2012). The protocol was applied from a 
holding potential (Vh) = -60 mV and the voltage protocol covered in the interval -140 to 
+20 mV to account for the more negative operating range of this transporter (Bossi et al., 
1999b). The staircase consisted of nine 20 mV steps of short duration because the decline 
of the presteady-state currents is much faster in this transporter. Fig.3.10 illustrates the 
results of this experiment. 
The current traces generated from the same KAAT1-expressing oocytes, in the absence or 
presence of 1 mM threonine, in response to this protocol at two fixed temperature (20 and 
30 °C) are shown in Fig. 3.10A and B; this amino acid used as substrate was been the 
threonine since it elicits a large transport current in KAAT1 when the driving ion is sodium 
(Soragna et al., 2004). These currents were strongly accelerated at the highest temperature 
and, accordingly the transport-associated currents became significantly larger. Dose-
response experiments were performed in a series of oocytes at these two temperatures in 
order to obtain the values of the maximal transport current (Imax) and the apparent affinity, 
in terms of the substrate concentration eliciting the half-maximal current (K05), by fitting 
the data to the Michaelis-Menten equation:     
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 (eq. 1) 
 
 
 
In the Fig. 3.10C and D it is possible to observe the results of this analysis: Imax was 
strongly increased at 30 °C compared to 20 °C, becoming similar to that observed in the 
oligopeptide transporter PepT1(Bossi et al., 2012); while the Q10 values are between 3 and 
4. 
The effect of temperature on K05 is shown in Fig.3.10, panel D: it showed an increase at 
more positive potentials confirming previous observations (Miszner et al., 2007), 
concerning the effects of temperature, a significant increase in the value of  K05 was 
evident at 30 °C  compared to 20 °C. 
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Fig.3.10: Temperature effects on the kinetic properties of KAAT1 with threonine as a substrate. Top row: 
currents in the absence (black) or presence (red) of 1 mM threonine at 20 °C (A) and 30 °C (B) in response 
to the staircase voltage protocol shown in the inset. The bottom row shows the results of the Michaelis-
Menten analysis performed on dose-response curves obtained using the same experimental protocol: voltage 
dependence of Imax (C) and of K05 (D) at the indicated temperatures. Data are means ± SE from six oocytes 
(two batches). The current data were normalized to the value at -120 mV and 20 °C for each oocyte before 
averaging. Some Imax and K05 values at the most positive potentials are omitted because their estimate is 
unreliable. All data at 30 °C (except the K05 value at -140 mV) were significantly different (P < 0.05) from 
those at 20 °C (Student’s t-test). 
 
 
3.2.2   Apparent affinity changes induced by temperature in rGAT1 
 
Previous experiments performed in the insect cotransporter KAAT1, illustrating changing 
in the apparent substrate affinity related to the increase of the temperature (as observed in 
PepT1), suggest that this phenomenon might be a common feature, with general relevance 
on the working mechanism of ion-coupled cotransporters, even belonging to different gene 
families. To reinforce this notion, the behaviour of another cotransporter belonging to the 
Na
+
/Cl
- 
family but originating from mammalian (homeotherm) animals, rGAT1, has been 
tested at the same temperatures in order to compare it with that of the model studied in this 
thesis. 
The same kind of experiment illustrated in Fig.3.10 was repeated on GAT1-expressing 
oocytes using GABA 300 µM as substrate.  
In this case (Fig.3.11), the holding potential was kept at -40 mV and the voltage protocol 
consisted of five steps, with longer duration compared to those used for KAAT1, because 
the decline of the presteady-state currents is much slower in this transporter. In fact, it was 
covered in the range from -120 to +40 mV in 40 mV intervals and the steps were 400 ms in 
duration to allow the complete decline of the presteady-state currents, particularly at the 
lowest temperature. The current traces generated from the oocytes in the absence or 
presence of GABA 300 µM, in response to this protocol at two fixed temperatures (20 and 
30 °C) are shown in Fig. 3.11A and B. As expected (Mager et al., 1993;Mager et al., 
1996;Forlani et al., 2001), the presteady-state currents visible in the absence of GABA 
(arrows) were abolished by its addition. Furthermore, as evidenced in KAAT1, even in 
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rGAT1 the transport associated currents (red colour) were strongly accelerated at the 
higher temperature and became significantly larger. 
Dose-response experiments were obtained in this case as well and the data were analysed 
with the Michaelis-Menten equation (eq. 1).  As illustrated in the Fig. 3.10C and D, raising 
the temperature from 20 to 30°C produced a considerable increase in Imax, which was larger 
than that observed previously in KAAT1 as well in the oligopeptide transporter 
PepT1(Bossi et al., 2012). 
Indeed, the action of temperature on K05 might be seen in the Fig.3.11,panel D: at 20 °C 
this parameter was voltage-dependent as previously reported (Fesce et al., 2002;Forlani et 
al., 2001;Mager et al., 1993), and increased at negative potentials, with values between 5 
and 20 µM. At 30 °C; in the same oocytes, K05 was significantly larger at all potentials, 
while the voltage-dependence was qualitatively preserved, differently from that exhibited 
by KAAT1 (Fig.3.10D).  
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Fig.3.11: Temperature effects on the kinetic properties of rRGAT1. Top row: currents in 
the absence (black) or presence (red) of 300 µM GABA at 20 °C (A) and 30 °C (B), in response to 
the staircase voltage protocol shown in the inset. The arrows point to the presteady-state currents that 
disappear in the presence of GABA. The bottom row shows the results of the Michaelis-Menten analysis 
performed on dose-response curves obtained using the same experimental protocol: voltage dependence of 
Imax (C) and of K05 (D) at the indicated temperatures. Data are means ± SE from seven oocytes (three 
batches). The current data were normalized to the value at -120 mV and 20 °C for each oocyte before  
 averaging. The K05 value at +40 mV is omitted because its estimate is unreliable. Data marked with 
asterisks were significantly different at the two temperatures (Student’s t-test, P < 0.05). 
 
 
3.2.3   Overall efficiency 
 
The increase in Imax and the decrease in apparent affinity reported above will be in contrast 
each other in determining the overall efficiency of the process. This parameter might be 
estimated, according to enzyme kinetics criteria (Stryer, 1988), as the ratio Imax /K05, and it 
has been plotted in Fig.3.12 (A and B) for the two transporters GAT1 and KAAT1. Our 
findings demonstrate that in both cases, the transport efficiency increased as the membrane 
potential was made more negative.  
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Fig.3.12: Temperature dependence of the efficiency of transport. The ratios Imax/K05 
have been calculated from the data in Fig. 3.10C and D for rRGAT1 and from the data in 
Fig. 3.11C and D for KAAT1. The values are in arbitrary units because of the normalization 
of the maximal current. Error bars are standard errors of the mean. 
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Both transporters did not show any statistically significant difference between 20 and 
30°C, especially in the physiological range of membrane potentials, around -70 mV for a 
neuronal presynaptic membrane, or surrounding glial cells, where rGAT1 is generally 
located, and at about -200 mV for the luminal side of absorptive intestinal cells, in the case 
of KAAT1(Dow, J.A.T. & Peacock, J. M.,1989). 
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4.1   KAAT1: the functional role of the highly conserved 
glycines triplet 
 
The analysis of the functional characteristics of native and mutated transporters, in general, 
can give some insight on the molecular mechanisms involved, and in some cases may 
allow the dissection of different protein functions.  
Glycine rotates easily and adds flexibility to the polypeptide chain because of the presence 
of two hydrogen atoms at the α-carbon. The importance of the flexibility conferred by 
glycine is proven by the fact that the K
+
 channel activation gate involves key identified 
hinge glycine residues (Chen et al., 2004b),  present in the M2 regions of K2P channels; 
indeed mutations of these glycines in both KCNK0 and in TASK3 (Rudnick & Clark, 
1993) led to a reduction in channel open probability. 
Furthermore, another evidence about the important role of the studied residues is given by 
the evidences that glycine-rich elements are described in binding sites of enzymes, such as 
protein kinases, in which the interaction with variable substrates requires the absence of 
steric restrictions at the binding site (Bossemeyer, 1994). In 2002, Jiang Y. and co-workers 
(Jiang et al., 2002) showed that a glycine residue may act as a gating-hinge in potassium 
channels; other evidences have been presented suggesting that glycine residues engineered 
into the proton-coupled lactose transporter confer conformational flexibility (Leyland & 
Dart, 2004). 
The high degree of conservation of the glycines residues in NSS transporters suggested a 
common relevant role in transport function that may be related to conformational 
flexibility.  Data obtained from the analysis of G85, G86 and G87 mutants in 
KAAT1(Giovanola et al., 2012) support this hypothesis, in fact this sequence is located at 
the extracellular side of protein, close to one of the residues that participates in the external 
gate (Arg 30 in LeuT, Arg 76 in KAAT1). 
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4.1.1   Cell surface expression of glycine mutants 
 
Cell surface expression evaluated by single-oocyte chemiluminescence (SOC) experiments 
allowed to exclude that the mutations in KAAT1 had caused a defective targeting to the 
plasma membrane. 
The results reported show that although with a variable expression level, glycine-alanine 
substitutions did not cause an evident alteration of surface localization related to the 
KAAT1 transporters: the three mutants (N84G, G86A, and A88G)  showed an expression 
comparable to the wild type transporter, while a reduced expression was seen for the three 
isoforms (G85A, G87A and G85A/A88G). The only exception was represented by the 
double mutant N84G/G87A, which was undetectable in the oocyte membrane, and 
obviously did not generate any transport-associated current.  
As many intestinal transporters, KAAT1 shows a broad substrate specificity that, in 
contrast to most mammalian homologues, is influenced by the driving ion (Castagna et al., 
1998;Soragna et al., 2004;Miszner et al., 2007). As mentioned in the  Introduction section, 
although KAAT1 utilizes K
+
 as driver ion for the transport of amino acid, it can also 
mediate a Na
+
 -coupled amino acid transport (and this ion can activate the amino acid 
transport even at low concentration) and Li
+
 (Bossi et al., 1999a;Castagna et al., 
1997;Hennigan et al., 1993a). 
 
4.1.2   Analysis of the transport activity of the glycine mutants 
 
A marked reduction of uptake and transport-associated currents has been observed for all 
the mutants compared with wt, for all tested substrates and in the presence of each of the 
driver cations of KAAT1. On one hand, it is possible that the low activity of the  glycine 
mutants analysed may reflect their degree of deviation from the native structure. 
As demonstrated in Fig.3.2, the only exception was represented by the G87A mutant that 
although exhibited a 50% reduction of surface expression, showed, in the presence of Na
+
, 
a proline uptake and proline and threonine transport- associated currents similar or even 
larger than the wt. Furthermore, not only the introduction of alanine increased the ion 
translocation in the absence of substrate, but this substitution in the presence of proline as 
substrate, showed also a transporter- dependent uncoupled current (Fig.3.4) (Peres & 
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Bossi, 2000). This current was observable in presence of both driven and driving substrates 
and manifested itself as a current in excess to that associated with the stoichiometric charge 
traslocation (Andrini et al., 2008;Perez-Siles et al., 2011). 
In the matter of the behavior of G87A mutant in the presence of Li
+ 
or K
+
, it was ween that 
it induced a leucine uptake significantly higher than wt protein (Figs.3.7, 3.8). 
 
 
4.1.3  Leak currents and Cation interaction 
 
Besides the transport-associated current, cotransporters may show one or two types of 
uncoupled currents (Perez-Siles et al., 2011). The behaviour of these currents was also 
investigated in the KAAT1 glycine mutants. 
It was possible to observe that in all the mutants the leak currents were altered, in 
particular the Li
+
 current was absent in G85A, and reduced in the G86A mutant. The G87A 
mutant showed instead the greatest current for all the three tested cations (Fig. 3.9). In the 
presence of K
+
, this mutant induced higher amino acid uptake than wt and reduced 
transport associated currents, revealing a partial uncoupling of amino acid and cation flux. 
For all the mutants, and in particular for G87A, an altered interaction with cations was 
therefore observed. 
Mutant transport activity was still Na
+
 dependent but their apparent affinity for the cation 
was different from that of the wt: it was reduced for G85A and G86A but increased for 
G87A  (Fig. 3.6). The alteration of the apparent affinity for Na
+ 
 might be explained by 
changes in the distribution of the inward and outward facing forms of these mutated 
transporters. These results suggest that TM1, close to the triplet, might play a role in the 
binding of sodium (Zhou et al., 2004). 
 
 
4.1.4   Conformational changes: involvement of the Glycine Triplet 
 
The external localization of the glycine stretch, its proximity to the external gate of the 
transporter, as well as its relevance in KAAT1 interaction with cations (Figs. 3.3; 3.5- 3.9)  
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suggested that the flexibility conferred by glycines may influence the conformation of the 
external vestibule of the transporter and alter the ions entrance. This would explain the 
evolutionary pressure that has determined the degree of conservation of the region. 
In a study on four membrane proteins with known tertiary structures the nature and 
distribution of glycines in transmembrane helices were compared (Cao et al., 1998); helical 
glycines appear predominantly to play a role as mediators of helix-helix interactions, in 
particular during conformational changes of membrane-spanning domains. Thus, glycine -
100 is potentially involved in a critical TM1-helix interaction needed to take place at some 
point during translocation (Kristensen et.al., 2004).  
The analysis of LeuT, in complex with different substrates and inhibitors and 
computational simulations based on structural data (Yamashita et al., 2005;Singh et al., 
2007;Zhao et al., 2011) have highlighted the functional importance of the extracellular 
vestibule of the transporter, where substrates and inhibitors appear not only to access but 
also to first interact with the protein. 
Site-directed spin labeling and electron paramagnetic resonance have shown that Na
+
 
favors accessibility to the extracellular vestibule basically through movements of the EL4 
and the TM1b segment (Claxton et al., 2010). Na
+
 binding increased accessibility at 
positions in TM1b, TM3 and EL4 that projects into the extracellular vestibule above the S1 
site. The glycine triplet flanks the TM1b segment, and may allow its movement. 
Taken together, the findings obtained from electrophysiological and uptake studies and 
those related to the cell surface expression allowed to characterize the roles of the 
individual determinants or in general of the entire glycine triplet in the transport function 
of KAAT1. 
Interestingly, the data reported in this thesis indicate that Na
+
 interacts with KAAT1 at 
least in two different regions: one located at the glycine loop (direct protection) and the 
other that should correspond to the internal Na
+ binding sites and that influences the 
conformation of the glycine loop. 
These findings may indicate that the glycine triplet in KAAT1 plays a multifunctional role: 
Gly 85 and Gly 87 are required for the complete surface expression of the transporter (Fig. 
3.2), the entire region is affected by the presence of Na
+
 and determines the access of 
cations to the extracellular vestibule of the transporter (Figs. 3.3; 3.7, 3.8, 3.9). The data 
presented for the G87A mutant are in agreement with observations made in GAT1 
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transporter (Zhou & Kanner, 2005), in which the corresponding G80A mutant showed 
increased apparent affinity for Na+ and a reduced flexibility that, in the absence of the 
cation, seemed to conditionally “freeze” the transporter in a state from which it could not 
further proceed in the transport cycle.  
It seems likely that also in other transporter families some of the conserved glycine 
residues may fulfill a role similar to that of glycine 80 in GAT1, or glycine 87 in KAAT1. 
However, the role played by the glycine triplet in KAAT1 appears more complex than that 
observed in GAT1 and SERT (Zhou & Kanner, 2005;Mao et al., 2008) and it might be 
related to the wider substrate specificity of intestinal amino acid transporters compared 
with neurotransmitter transporters. Obviously, in order to fully understand and appreciate 
the biological and pharmacological properties unique to human secondary transporters, the 
atomic structure of eukaryotic homologues must be obtained. 
 
 
4.2  Temperature effects on two ion-coupled cotransporters 
 
The possibility of heterologous expression in Xenopus laevis oocytes has greatly expanded 
our knowledge of the properties of several cotransporters. However, in the majority of the 
cases, the experiments have been performed at room temperature (Forster et al., 
2000;Binda et al., 2002;Forster et al., 2006) a situation that, while necessary to keep the 
amphibian oocytes in optimal condition, is certainly not physiological for the mammalian 
transporters often used. This limitation prevents a full knowledge of the properties of a 
mammalian protein under study. Commonly oocytes studies are performed at room 
temperature (22±2°C), irrespective of the thermoregulation characteristic of the species. 
The interest of our experiments to investigate temperature effects on the functioning of two 
ion-coupled cotransporters originated from different species is two-fold: on one hand to 
acquire data on the kinetic properties of the system at more physiological temperatures 
and, on the other, to gain new insights on the molecular processes involved, on the basis of 
the Q10 values. 
All ion-coupled cotransporters tested so far to investigate the effects of temperature have 
shown changes in transport activity with Q10 values of about 3 or (Hilgemann & Lu, 
1999;Hazama et al., 1997;Beckman & Quick, 2001;Broer, 2002;Binda et al., 2002;Bossi et 
74 
 
al., 2012). Just to quickly summarize, Q10 values below 1.5 are indicative of diffusional 
processes, while conformational changes are generally characterised by a stronger 
temperature dependence and therefore by higher Q10 values. 
The large effects reported in Chapter 3 (Section 3.2), imply high activation energies for the 
rate-limiting step in the process, in the range of several tens of kJ/mole, and confirm 
therefore that the transport process could involve a relevant conformational change of the 
protein. 
 
 
4.2.1  Affinity changes induced by temperature in KAAT1 and rGAT1  
 
For both the cotransporters, the effects of the temperature suggested that the apparent 
affinity might also be affected.  
First, a strong increase in the transmembrane current generated by the presence of the 
specific substrates, as well a faster decline of the transient currents, was observed at higher 
temperature (30°C)  (Figs.3.10, 3.11, A and B). As previously reported  (Binda et al., 
2002), this kind of effect reflects the acceleration in the rate costants of the intramembrane 
charge movement that underlies these currents. Then, when the maximal transport-
associated current (Imax) and the apparent substrate affinity (K05) were measured, both 
transporters showed greater K05 values (i.e. a decrease in affinity) at higher temperatures. 
In particular in KAAT1, a considerable increase in Imax was observed (Fig.3.10C); this 
increase was not as large as in the case of GAT1 (Fig.3.11C), but it was instead similar to 
that observed previously in the rabbit oligopeptide transporter PepT1(Bossi et al., 2012). 
Furthermore, in rGAT1, Q10 values was higher than those reported before (Binda et al., 
2002) however, it might be noted that the previous data were obtained using a fixed GABA 
concentration and therefore, did not account for changes in apparent affinity. 
Concerning the voltage-dependence of K05, it may be noted that this parameter at 20°C  
(Fig.3.10D) was different from that exhibited by rGAT1 (Fig.3.11D), i.e. it showed an 
increase at more positive potentials rather than a decrease; in fact this behaviour confirms 
previous determinations (Miszner et al., 2007) and it is very likely related to the different 
characteristics of the presteady-state currents in the two transporters (Soragna et al., 2005; 
Bossi et al, 1999) . 
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These results, confirming the effect already observed in PepT1 (Bossi et al., 2012), suggest 
that this phenomenon might be a common feature, with general relevance on the working 
mechanism of ion-coupled cotransporters (Beckman & Quick, 2001), even belonging to 
different gene families. Furthermore, it should be noted that GAT1, a rat neuronal GABA 
transporter, belongs to a mammalian (homeotherm) animals, while KAAT1, the neutral 
amino acid transporter cloned from the gut of the inverterbrate Manduca sexta (Castagna et 
al., 1998), originates from a poikilotherm animal (Castagna et al., 2009).  
As introducted in Chapter  1, although clearly not a neurotransmitter transporter, KAAT1 
has a significant homology with the mammalian neutral amino acid transporter B
0
AT1, 
another member of the SLC6A family (Boudko et al., 2005;Camargo et al., 2005); in fact, 
it represents a good model to study the functional mechanisms of transporter belonging to 
this important family. 
The fact that both GAT1, involved in many important physiopathological issues, and 
KAAT1 (Peres et al., 2012) exhibit the same behaviour previously observed in PepT1, 
confirms similar results reported in an earlier papers on the noradrenaline transporter and 
on the Drosophila serotonin transporter (Beckman & Quick, 2001). However, it must be 
also noted that  no temperature-induced changes in apparent affinity were observed in the 
human form of GAT1 (Gonzales et al., 2007).  
The observation that the apparent substrate affinity is inversely related to the transport rate 
suggests a kinetic regulation of this parameter. In addition, the present results indicate that 
the affinities estimated at room temperature for mammalian cotransporters may not be 
simply extrapolated to their physiological operating conditions. A possible explanation for 
this behaviour may be directly found in the transport mechanism which, for the 
transporters under consideration appears very similar (Fesce et al., 2002;Sala-Rabanal et 
al., 2006;Renna et al., 2011). In these transporters, the initial steps of the cycle, involving 
the interaction with the driving ion(s) and the following intramembrane charge movement, 
precede the binding of the organic substrate. Furthermore, these steps are rate-limiting of 
the entire transport cycle (Nussberger et al., 1997). Consequently, the lifetime of the 
conformational state in which substrate binding can occur will be shortened when the 
turnover rate is increased (e.g. in the present case, by a higher temperature). A shorter life 
time of this state implies that a higher concentration of substrate will be needed to sustain 
the high turnover rate, leading therefore to a decreased apparent affinity. 
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4.2.2   Overall efficiency 
 
The overall efficiency of the co-transporters GAT1 and KAAT1 estimated as the ratio 
Imax/K05, demonstrate that in both cases, increases as the membrane potential is made more 
negative. 
Nevertheless, no statistically significant differences between 20 and 30°C are observed in 
both transporters, in particular in the physiological range of membrane potentials, around -
70 mV for a neuronal presynaptic membrane, or surrounding glial cells, where rGAT1 is 
generally located, and at about -200 mV for the luminal side of absorptive intestinal cells, 
in the case of KAAT1 (Dow, J.A.T.& Peacock, J.M, 1989).  
However, it must be kept in mind that the lipid membrane composition of the Xenopus 
oocyte is unlikely to be the same of a mammalian or of a Manduca sexta cell, and 
therefore, the present results cannot be directly extrapolated to the respective native 
conditions in which the transporter physiologically operate. The observations obtained in 
these studies might lead to the idea that the mammalian transporters, at their physiological 
body temperature, might be much more efficient in substrate translocation. The overall 
transport efficiency will obviously depend on the apparent affinity of the transporter for the 
substrate. 
Since the increased Imax at higher temperature is counterbalanced by a lower apparent 
affinity, and the two effects approximately compensate for each other, both in rGAT1 and 
KAAT1,  the efficiency, estimated as the ratio Imax/K05, could appears temperature-
independent. 
In the case of the GABA transporter, the lower apparent affinity at higher temperature is 
likely to produce consequences on the basal extracellular levels of the neurotransmitter, 
which are known to be very important in neurological pathophysiology (Richerson & Wu, 
2003;Richerson & Wu, 2004).  
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The work of my PhD research allowed to identify relevant properties of KAAT1, that in 
addition to its role in the nutrient transport in the insects, represents a good model for the 
understanding of the molecular physiology of NSS transporters.  
Taken together, the findings obtained from electrophysiological and uptake studies and 
those related to the cell surface expression allowed to characterize the roles of the 
individual determinants or in general of the entire glycine triplet in the transport function 
of KAAT1. The results shown in Fig.3.2 indicate that the behavior of all the glycines 
mutants tested could fully explain the changes observed in transport activity 
(Figs.3.3;3.4;3.5). As most intestinal transporters, KAAT1 shows a broad substrate 
specificity that, in contrast to most mammalian homologues, is influenced by the driving 
ion (Castagna et al., 1998;Soragna et al., 2004;Miszner et al., 2007); this observation may 
explain the complex role played by the glycine triplet under study. It allows the initial steps 
of cation interaction with the transporter; a multifunctional role is also demonstrated by the 
fact that Gly 85 and Gly 87 are required for the complete surface expression of the 
transporter (Fig.3.2); moreover, the entire region is affected by the presence of Na
+
 and 
determines the access of cations to the extracellular vestibule of the transporter (Figs.3.3; 
3.7; 3.8; 3.9).  
Furthermore, the alanine scanning mutagenesis approach supported the hypothesis of a 
relevant role of the glycine triplet in the transport function, possibly related to 
conformational flexibility. The importance of the flexibility provided by glycine,  an amino 
acid with no side chain, was proven in the literature (Rudnick & Clark, 1993) as well the 
high degree of conservation of the triplet among the NSS family members. The external 
localization of the glycine stretch, its proximity to the external gate of the transporter, as 
well as its relevance in KAAT1 interaction with cations (Figs. 3.3; 3.5- 3.9) suggested that 
the flexibility conferred by glycines may influence the conformation of the external 
vestibule of the transporter (where substrates seem to access and to interact with the 
protein) and alter the ions entrance. This would explain the evolutionary pressure that has 
determined the degree of conservation of the region. 
The integration of structural and computational analysis of LeuT has originated the 
conception of two different transport models, one based on a “rocking bundle” of 
transmembrane helices allowing the alternation of the transporter between an inward 
facing and an outward facing conformation (Forrest et al., 2008) and the other outlining the 
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role of an external and an internal gate in controlling the access to the central binding site 
(Krishnamurthy et al., 2009). 
In the first model, TM 1, 2, 6 and 7 form a bundle of four associated helices involved in a 
rocking movement relative to the other transmembrane domains (scaffold) that allows for 
conformational transitions; data reported in this thesis indicate that the transport process 
requires reciprocal movements between TM1 and TM2, that can be allowed by the 
conserved flexible glycine loop. These observations may be of relevance to other 
transporter families, many of which contain internal inverted repeats. 
In the experiments about the temperature effects it was been possible to acquire a better 
knowledge of the kinetic properties of the cotransport system at more physiological 
temperatures. Raising the temperature from 20 (temperature normally used to perform 
electrophysiological measurement in X. laevis oocytes) to 30°C, a strong acceleration of 
the presteady-state currents as well as a significant increase in the transport-associated 
currents was produced in both the cotransporters (Figs.3.10 A and B; 3.11 A and B). 
Changes in transport activity with Q10 values bigger than 3 imply high activation energies 
for the rate-limiting step in the process, in the range of several tens of kiloJoules per mole 
(kJ/mol) and confirm, therefore, that the transport process must involve a relevant 
conformational change of the protein. 
Moreover, the increase of both Imax (stronger in the case of rGAT1) and K0,5 (that showed a 
different voltage-dependence in the two cotransporters under study (Figs.3.10D and 
3.11D), confirmed previous observations obtained in the intestinal PepT1 transporter 
(Bossi et al., 2012), showing an increased transport efficiency at negative potentials. The 
inverse relationship between the Imax and the apparent affinity suggests that the two effects 
approximately compensate for each other, so that the efficiency, estimated as the ratio 
Imax/K0,5, would appear to be temperature-indipendent. 
It is possible to conclude that a change in apparent affinity with temperature might be a 
feature shared by different transporters, even those belonging to diverse gene families. 
Finally, the functional and structural similarity of KAAT1 to the mammalian neutral amino 
acid transporter B
0
AT1, member of the SLC6A family, as well to many others members of 
the same family might allow to utilize this insect cotransporter as a model, in order to 
promote a better understanding of the functional mechanisms of the Na
+
/Cl
-
-dependent 
cotransporters implied in neurological pathophysiology. 
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